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ABSTRACT
The Covalent Interaction of Hepatic Metabolites of the
Insecticide Chlordane with Cellular Macromolecules
in the Rat and Mouse In Vitro
by
Alan A. Brimfield, Doctor of Philosophy
Utah State University, 1979
Major Professor: Joseph C. Street
Department: Interdepartmental Program in Toxicology
This investigation addressed several aspects of the covalent
interaction of metabolites of the insecticide chlordane with cellular
macromolecules in vitro.

Microsomal preparations from the liver of

mice and rats were used and covalent binding to microsomal protein and
RNA or to added calf thymus DNA was studied.

Pure

14 C-labelled

and trans-chlordane isomers as well as an isomeric mixture
chlordane plus

14 C-trans-chlordane

for the in vitro system.

cis-

( 14 C-cis-

3:1, w:w) were used as substrates

Biochemical parameters investigated

included inhibition of microsomal mixed-function oxidase and epoxide
hydratase plus the induction of these enzymes by pretreatment with
chlordane or phenobarbital.

The effect of these manipulation s on

covalent binding of the metabolites to the macromolecules was of
interest.
Isolation of the protein, RNA and DNA from the in vitro
microsomal systems and determination of unextractable radioactivity
indicated that the chlordane derived material bound to each of the

X

macromolecules investigated.

The only exception was that mouse liver

microsomes did not activate trans-chlordane to a form which bound to
DNA in measurable amounts under the conditions employed.
Microsomal epoxi de hydratase and aminopyrine demethylase activity
were increased in both the rat and the mouse following chlordane pretreatment.

The effect of this induction on the macromolecul ar inter-

action of chlordane metabolites was variable for both chlordane and
phenobarbital pretreated groups.

Generally, for the mouse, induction

increased binding to protein and DNA but decreased binding to RNA.
In the rat, induction decreased binding to each of the macromolecular
species.

The effect of enzyme inhibition was variable in both species

under the different conditions tested except for the binding of cischlordane derived material to DNA in the mouse liver system.

In that

case inhibition of epoxide hydratase clearly reduced the concentration
of material covalently interacting with the DNA to unmeasurable
levels.
The results indicated little possibility that the primary epoxide
metabolite of chlordane, oxychlordane, is involved in the binding.
The effects of epoxide hydratase inhibition, however, indicate that
some secondary epoxide is involved in the cis-chlordane binding to
DNA in the mouse.

The possible analogy between the binding behavior

of chlordane found in this study and the binding behavior of other
well characterized toxic compounds is discussed.

(154 pages)

INTRODUCTION
Whatever effects a drug produces in a biologic system
must be regarded as ultimate consequences of physicochemical
interaction between that drug and functionally important
molecules in the living system (1) .
This bit of pharmacologic dogma whose origins can be traced to
the work of Paul Ehrlich communicates the basic concept from which
the theory of the molecular basis for drug action has evolved.

If

the word "drug" in the quotation is generalized to "chemical", a
justification develops for the kind of work described here.

Drugs

are only a specialized class of chemicals whose biological effects
are beneficial within carefully defined limits of dose, dose rate
and clinical circumstances.

The concept of drug-receptor inter-

action lies at the foundation of effects produced by all biologically active chemicals whether or not they produce beneficial results.
The quotation, simply stated, says that if there is an effect
there must have been a physicochemical interaction.

The converse of

this statement would be:

If there is a physicochemical interaction

there must be an effect.

It doe s not take an adventuresome soul to

suggest that this statement would be received with considerable
skepticism on the part of scientists.

Yet it may well be true if one

considers that an effect can be long delayed or manifest itself in
a way that obscures its origin.
It has been established over the past several decades that a
variety of organic compounds are metabolized in the liver to forms
which interact covalently with cellular proteins, nucleic acids and/or

phospholipids (2).

In fact, it is becoming clear that many of the

chemicals that man is exposed to and which are suspected of toxicity
share this characteristic.

Such a process has been evoked as a step

in the molecular mode of action of various hepatotoxins (3), carcinogens (4), mutagens (5) and compounds precipitating allergic reactions
(6) and blood dyscrasias (7).
Preliminary experiments with the chlorinated insecticide chlordane! showed that after microsomal metabolism a portion of the insecticide remained tenaciously bound to the acid precipitable microsomal
residuum.

The additional knowledge that chlordane is metabolized to

an epoxide and is known to be a carcinogen in rodents indicated that
a further investigation of chlordane binding might be a fruitful path
of inquiry.
11,2,4 , 5,6,7,8,8-octachloro-3a-4,7,7a-tetrahydro-4,7-methanoindane.
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REVIEW OF LITERATURE
Chlordane:

Background ann Administrative
History

Background
Chlordane was introduced as an insecticide for agricul tural use
in 1945 (8).

As incorporated into commercial formulations it is a

yellow oil commonly referred to as technical chlordane.

Recent work

has shown that it is a mixture of at least 26 separate compounds of
which 11 have been characterized (9).

These ll compounds account for

approximately 40% of the material in the oil (10).

Significant among

these are chlordene, 0.3%; heptachlor, 5.0%; cis-chlordane, 8.3%;
trans-chlordane, 9.2% and trans-nonachlor, 3.7% (listed as percent of
the technical mixture) (9).
Commercial synthesis of technical chlordane is achieved by the
Diels-Alder condensation of cyclopentadiene with hexachlorocyclopentadiene to yield chlordene which is subsequently chlorinated (10).
process yields the heterogeneous oily mixture described above.

This
Pure

chlordane is a white crystalline solid consisting of cis- and transisomers.

Cis-chlordane has a melting point of 106.6-108° and pure

trans-chlordane melts in the range 104.6-106° (10).

These compounds

are virtually insoluble in water but are soluble in a wide range of
organic solvents (11).

They are extremely lipoph i l ic (11).

Technical chlordane has a relatively low toxicity to mammals on
an acute basis.

This characteristic plus its resistance t o
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environmental breakdown make it a valuable insecticide (11).

It is a

broad spectrum insecticide whose principal use in agriculture is in
the control of soil insects attacking root crops and the root systems
of field crops .

Total use of chlordane for these and other purposes

in United States agriculture for 1971 was 1.5 million pounds (11).
The second most widespread use of chlordane is in the home owner's
market where it finds use as a long lasting barrier to the entry of
crawling insects and is widely used to control insects damaging turf,
ornamental plantings and home vegetable gardens (11).

Chlordane has

also found wide use in the prevention of damage to structural timber
and forest products by termites and wood boring insects.

Its persist-

ence has made it an ideal pest control agent from an economic standpoint because of the infrequent applications needed and the resulting
low cost (11) .
Administrative history
Federal regulatory officials and environmentalists have also
noticed chlordane's environmental persistence.

From their point of

view persistence was equated to an increased opportunity for the
exposure of nontarget species to its toxic effects.

Potential for

danger to the human population was first recognized officially in 1955
when tolerances of 0.3 ppm were established for chlordane residues on
fruits and vegetables under the Federal Food, Drug and Cosmetic Act
(12) .
This decision was reviewed by the Food and Drug Administration
in 1963 (12).

But at that time there was no evidence that chlordane

caused tumors or any other permanent pathological change in humans.
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Neither had there been any indication of deleterious effects on
workers engaged in the manufacture or application of chlordane.

The

1955 tolerances were allowed to stand (12).
In October of 1974 a petition was filed with the Environmental
Protection Agency (EPA) for cancellation of the registration of chlordane and heptachlor by attorneys for the Environmental Defense Fund
(EDF) (14) .

In accordance with the Federal Insecticide, Fungicide and

Rodenticide Act, EPA Administrator Russel E. Train issued a Notice of
Intent to Cancel Registration for chlordane and heptachlor on November
18, 1974.

The EDF petition and the Notice of Intent contended that

chlordane and heptachlor were ubiquitous environmental contaminants
subject to biomagnification.

Additionally, they maintained that

chlordane and heptachlor and their metabolites were present in the
tissues of 90% of the United States population and that the insecticides and their metabolites had been shown to pose a cancer risk to
humans (15, 16) .
The Velsicol Chemical Co., the Department of Agriculture (USDA)
and several others contested the allegations in the Notice of Intent
to Cancel and requested a hearing (14).

The request was granted and

the hearings began after a lengthy pretrial process (16).
Just after the cancellation hearings had begun, Administrator
Train issued a Not:ice of Int:ent t:o Suspend Registration for hept:achlor
and chlordane based on the principle of imminent hazard (16).

Receipt

of the results of a review of tissue slides from animal feeding
studies, the results of human adipose tissue analyses for 1973 and a
study of pesticide residues in the milk of US mothers convinced him
that suspension was warranted.

The notice was published on August 15,
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1975.

The cancellation hearing was recessed and a suspension hearing

was convened in the same month.
The areas of contention were the same in these hearings as they
had been in the cancellation hearings.

The registrants challenged

the scientific validity of the EPA's principles for evaluating carcinogenic hazard and the interpretation of the tissue slides from the
feeding studies.

Velsicol's pathologists maintained that the irregu-

larities seen in rodent liver on the slides were not indicative of
cancer while EPA's pathologists insisted that they were (14).
The Administrative Law Judge finally issued a decision on
December 12, 1975 in which he dismissed the suspension notice.

The

decision turned on the fact that the differences in interpretation
left him no basis on which to find chlordane and heptachlor carcinogenic.

The judge felt that he was not competant to find one side or

the other in error in their appraisal (17).

Administrator Train

immediately overturned this decision citing as precedent the principles
for the evaluation of carcinogens as they had been applied to other
insecticides and his authority under the Federal Insecticide, Fungicide and Rodenticide Act (18).
The cancellation hearings resumed in June of 1976.

A year later

Velsicol and USDA were finally successful in getting the question of
the carcinogenicity of heptachlor and chlordane submitted to a committee of the National Academy of Sciences.

The material to be evaluated

was sent to the committee on June 15, 1977 (13).
given specific questions to answer.

The committee was

Primary among these was the

question of the carcinogenicity of the two pesticides in rats and mice.
The reviewing pathologists were of the opinion that chlordane and
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heptachlor were carcinogens in the mouse and may have been carcinogens
in the rat (7).

They informed the judge that they could not make a

determination of the risk that these compounds posed for man nor
coul d they say what constituted a safe limit of exposure for man (7).
The cancellation hearings dragged on until the spring of 1978
when a negotiated settlement was reached without an actual verdict.
The point of cancellation of the registration was, by now, a
moot one.

The registration had already been suspended (18).
Recent Work Linking Chlordane to Canc er
and Other Health Problems

Epidemiological evidence linking chlordane to cancer in humans
and to certain blood dyscrasias has come to light in the past few
years.

The evidence seems to correlate with the use of chlordane in

the home rather than in agriculture.
Furie and Trubowitz (19) related the case of a 56 year old man who
developed refractory megaloblastic anemia after treating his office
for termites

with a 74% solution of chlordane.

The route of exposure

seems to have been skin contact and inhalation.
Additional evidence of a link between chlordane and human health
problems comes from epidemiological data generated for a second study
(6).

This relates 5 cases of neuroblastoma reported between 1974 and

1976 in which pre or postnatal exposure to chlordane is felt to have
been the primary cause or a contributing cause.

Six other cases,

unrelated to those with neuroblastoma, were discussed.

These dealt

with older people who had developed aplastic anemia or leuk emia.
Each of the neuroblastoma patients had a history of chlordane
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exposure from home extermination processes.

In 4 of the 5 cases this

was for termite control and the indication was that the treatments
were by professional applicators although this was not stated in the
text.

The children were between the ages of 2 1/2 and 6 years old .
The blood dyscrasia cases were older people and usually followed

the use of the insecticide by the patient.

The circumstances were

similar to those in the Furie and Trubowitz report (19).

The age

range was from 15 to 68 years old.
In defense of chlordane it should be pointed out that the use of
the insecticide by these individuals had been extensive and proper
precautions do not seem to have been taken.
was purely circumstantial.

The link to chlordane

In most of the cases there had been

exposure to other chemicals as well.
Chemically Induced Pathological
Conditions:

An Overview

The role of the liver microsomal enzymes
The mammalian organs that lie at the interface with the environment are faced with the task of keeping the body free of harmful chemical substances.

In addition to acting as physical barriers to

contamination, these organs also possess the enzymatic capacity to
neutralize intruding toxic molecules.

Although the liver is not at

the environmental interface in the strictist sense, it sits astride
the incoming blood supply from the gut via the portal vein.

Conse-

quently, it has evolved an enzymatic xenobiotic metabolizing repertoire qualitatively similar to that found in the skin and lung but of
greater capacity.
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The liver system probably arose to neutralize the plant pigments, alkaloids and toxins that are absorbed with the nutritionally
useful constituents of food (20).

More recently , the use of fossil

fuels for energy production and the use of drugs and organic chemical
products in consumer goods and agriculture has added to the burden.
The phrase "liver xenobiotic metabolism system" has now become
synonymous with the group of enzymes that perform hydrolysis, oxidation, reduction and conjugation reactions on a staggering number of
food additives, drugs and environmental contaminants as well as on
the non-nutritive constituents of food.
The enzymes that provide the cells of the liver with the capacity
to transform exogenous chemicals can be placed into two categories
corresponding to the tissue fractions from which they are isolated.
Esterases, amidases (21), sulfotransferases and acetyltransferases
(22) are found in the cytoplasmic fraction.

A second group of

enzymes is found in the microsomes, which is the term used to des cribe the isolable remnants of the membranes of the endoplasmic
reticulum.

The microsomal enzymes are a membrane bound group that

consists of severa l cytochromes with reductive (23, 24, 25) and
oxidative (21) capabilities, hepatic epoxide hydratase (HEH) (26)
and glucuronyl transferase (21) among others.

One function of both

of these groups of enzymes is t o render foreign molecules suitable for
excretion.

The process usually leads to detoxification as well.

As a group, the hepatic enzymes are the body's major defense
against blood borne toxic chemicals regardless of their origin .

The

work described here involves the membrane bound group; specifically,
the mixed-function oxidases (MFO) and HEH.
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In vivo the xenobiotic metabolizing enzymes usually act in
concert or sequentially.
naphthyl ester.

A hypothetical example might be that of a

Metabolism might proceed simultaneously by esterase

and MFO action to yield, respectively, a carboxylic acid and a
naphthol, and an epoxide.

The naphthol could be conjugated by

glucuronyl transferase for excretion.

The epoxide could be cleaved

by epoxide hydratase and excreted, or conjugated directly by
glutathione-S-epoxide transferase (a sulfotransferase) for excretion
as a mercapturic acid.

Alternatively, the naphthyl ester could simply

be hydroxylated by the mixed-function oxidases prior to glucuronide
formation and excretion.

Obviously a wide variety of transformations

is possible.
The broad spectrum of reactions catalysed by the hepatic enzymes
can be a mixed blessing.

In the case of some organic molecules,

enzymatic transformations may represent toxicant activation rather
than detoxication.

The phosphorothionates, exemplified by parathion,

have no activity toward acetylcholinesterase until they are oxidized
to phosphates by the mixed-function oxidases of the liver (27).

This

is a perfect illustration of the classic "lethal synthesis" found by
Peters (28) to account for the devastating acute toxicity of fluoroacetate.
"Toxic synthesis" in the case of short lived compounds of relatively limited availability is a dangerous but controllable situation.
It becomes another matter when it involves drugs, long lived environmental contaminants or chemicals used in the home or the workplace.
A pattern has been developing in which previously unexplained
pathological conditions have been found to result from a series of
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events initiated by exposure to a chemical that was thought to be
innocuous.

The suspected active "agent" is generally a metabolic

product of the MFO and represents the product of a toxic synthesis.
Some conditions whose etiologies involve this pattern are discussed
below.
Chemical carcinogenesis
This is a broad topic involving many toxic chemicals and many
target organs.

This section will be confined to a discussion of the

mechanism of action of the polycyclic aromatic hydrocarbons.
The carcinogenic properties of these derivatives of coal tar have
been known since the eighteenth century.

Their ability to cause

cancer in experimental animals was first reported in 1916 (28).
Among the polycyclic aromatic hydrocarbons isolable from coal tar
it is only those compounds that contain a phenanthrene nucleus (I,
f ig . 1) plus one additional benzene nucleus that are carcinogenic (1).
The structures of several of these compounds are given in figure 1.
The mo st widely studied of the polycyclic aromatic hydrocarbon carcinogens have been benzo(a)pyrene and dibenzanthracene (II, III, Fig. 1)
probably due to the fact that they are constituents of tobacco smoke
and tars (1).
The course of chemical carcinogenesis has been shown to involve
two phases termed initiation and promotion (1).

The first involves

enzymatic conversion of the parent compound (procarcinogen) to the
activated intermediate(s) (proximate carcinogen) (30).

This metabo-

lite is the ultimate source of cell damage, a characteristic of
initiation, and is a stable alkylating or arylating agent (29) .

The
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I

n

IV
Figure 1.

Structural formulas for several of the polycyclic aromatic
hydrocarbon carcinogens. I Phenanthrene. II Benzpyrene.
III Dibenzanthracene. IV 3-Methylcholanthrene.

lesion itself is felt to be the covalent interaction of this activated
intermediate with a site or sites on one or more of the cellular
macromolecules (1, 30-33).
Covalent interaction triggers the second or promotion stage.
Cells surviving the disruption of their biochemical apparatus by
exposure to the activated intermediate are somehow transformed to
cancer cells.

The specifics of the transformation process up to the

point of the appearance of a clone of cancer cells are poorly understood.

However, several theories that attempt to explain the process

have arisen out of the study of the initiation process.

The somatic

mutation theory advances the point of view that transformation occurs
as a result of a permanent change in the cell genome caused by
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irreversible binding of the proximate carcinogen to the cellular DNA
(29).

That is, the cancer arises from a chemically induced mutation.

This is a widely accepted point of view and it gains credibility from
the fact that many carcinogens are known to be mutagens as well (5).
A second theory has been advanced that presents a rationalization based on the interaction of the proximate carcinogen with cellular protein without direct involvement of the genetic material (34).
Promotion, in this case, is hypothesized to be the result of covalent
interaction with proteins that control the expression of the genetic
material, the repressor and derepressor proteins.

This is based on

the fact that transformed cells have been shown to be deficient in
certain proteins or groups of proteins.
Activation and binding of polycyclic aromatic hydrocarbons.

It

ha s been known for some time that benzo(a)pyrene is metabolized in
vivo (35, 36) and in vitro (31, 37) by MFO's to compounds that bind
covalently to nucleic acids and proteins.

Understanding of the

activation process and the isolation of the activated intermediates
are the result of more recent work (38).

This metabolic activation

plays such an important role in the initiation process that it will
be informative to consider it.
Inv estigations of MFO metabolism of benzo(a)pyrene have shown
that a complicated pattern of eight or more transformation products
results (39).

The presence of phenolic, quinone and epoxide metabo-

lites has been demonstrated (39, 40) and testifies to the complexity
of the process.

The presence of dihydrodiols strongly suggests the

participation of HEH.
hibitors (39, 40, 41).

This has been verified by the use of inEarly work indicated the direct participation
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of the 4,5-epoxide (the K region epoxide) in the initiation process .
This theory has largely been supplanted by evidence in favor of one
or more diolepoxides that have been isolated as nucleotide adducts
(38, 42).
The process of metabolism, then, can be described as one involving a spectrum of reactions.

MFO's perform both detoxification and

activation reactions when confronted with benzo(a)pyrene.

The detox-

ification reactions give rise directly to phenolic and quinone
products.

Indirect detoxification results when epoxides spontaneously

rearrange to phenols (26).

Work has shown that conjugation reactions

participate, as well, giving rise to sulfates, premercapturic acids
and glucuronides (43).

These are primarily detoxifications although

there are indications that glucuronides may be cleaved at sites
remote from their formation and resume their role as carcinogens
(43).

The action of glutathione-S-epoxide transferase on epoxide

metabolites neutralizes the epoxides to some extent (26).

This is

illustrated by the fact that inhibitors of this enzyme cause an
increase in covalent binding (26, 39-41).

The isolation of the diol-

epoxide, 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene-9,10-oxide, as an
adduct of DNA (38) and the study of the production of this compound
(42) further testifies to the fact that HEH is an activator.

The

process (figure 2) involves an initial epoxidation at the 7,8-position by the MFO's followed by hydrolysis to a 7,8-dihydrodiol.

The

resulting non-aromatic double bond at the 9,10-position is then
epoxidized in another cycle through the MFO's leading to the major
proximate carcinogen of benzo(a)pyrene (38, 42) .
Mechanism of benzo(a)pyrene-DNA adduct formation.

The potential
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that this diol-epoxide has for damage to nucleic acids and a
plausible mechanism to explain its action have been reported by
Gamper, et al. (44) .

The anti-7,8-dihydroxy-7,8-dihydrobenzo(a);

pyrene-9,10-oxide, formed by the MFO's, reacted with RNA and DNA in
vitro to give covalent adducts.

The reaction with RNA was known to

involve the 2-amino group of guanine and C-10 on the hydrocarbon.

The

product of the arylation of DNA was a hydrocarbon phosphate ester
(fig. 2) again involving C-10.

This then rearranged to yield a phos-

photriester which hydrolysed and led to DNA strand scission (44)
(fig. 2).
The devastating effect of this interaction was

sho•~

by using

E. coli plasmid Col El, a superhelical circular DNA (form I in the
terminology of Gamper, et al.).

Cleavage of one phosphodiester link-

age by diol-epoxide DNA interaction allowed unwinding of the strands
and des troyed the circular configuration (form II).

Cleavage of a

s econd l i nkage ga ve rise to linear fragments (form III) .

This

process was followed by electron microscopy and electrophoresis.

The

results indicated that the lowest ratio of diol-epoxide to mononucleotide that gave strand cleavage to form II was 0.01.

At ratios between

0.5 and 1.0 no form I DNA remained after two hours of incubation (44).
The sequence by which this effect is translated into carcinogenesis is unclear.

The somatic mutation theory is still in vogue (30).

However, considering the fact that gross disruption of the genetic
material of the cell usually results in cell death (45) one cannot
avoid the conclusion that faulty nucleic acid repair or a change in
the mechanism by which gene expression is controlled (46) may be
involved in the transformation process.

Furthermore, the fact that
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The proposed mechanism for benzpyrene-DNA adduct formation.
Redrawn from (45).
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arene oxides and free radicals are also found as the result of the
metabolism of benzo(a)pyrene (32) leaves some doubt about the identity
of the proximate carcinogen.
Hepatotoxicity arising from halogenated
hydrocarbons
A second pathological condition that requires comment in this
context is the hepatotoxicity that results from mammalian exposure to
some of the halogenated hydrocarbons.

The toxic lesion in this case

is liver necrosis although compounds in this class have been implicated in other disorders as well (47, 48).
The specific biochemical events leading to necrosis are still
not well understood.

As is the case with the carcinogens, the

compounds that cause necrosis are known to be metabolically activated
by the liver microsomal enzymes and to bind to cellular macromolecule s (48).

Unlike the polycyclic aromatic hydrocarbons, where

binding to nucleic acids is felt to be significant, the necrogenic
halogenated hydrocarbons seem to interact predominantly with cellular
protein (49, 50, 51) and lipids (50, 52).

For example, in experiments

designed to detect binding to nucleic acids by halogenated benzenes
no evidence of interaction with DNA or RNA could be demonstrated
(49).

The protein and lipid binding activity, however, ha s been

demonstrated both in vivo (49) and in vitro (50).

Centrilobular

hepatic necrosis has been reported to occur following mammalian
exposure to halothane (53), bromobenzene, ortho-dichlorobenzene,
iodobenzene (49), trichloroethylene (51) and carbon tetrachloride
(50, 52).

Definitive work has been carried out using bromobenzene and

carbon tetrachloride,

The details of the metabolic activation and
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mode of action of these two compounds serve to illustrate the
behavior of the group.
Bromobenzene induced hepatotoxicity.

Exposure of rats to single

doses of bromobenzene has been shown to initiate a reproducible
series of biochemical events.

Centrilobular hepatocytes become

depleted in glycogen at 12-16 hours.

Necrosis follows beginning

after 24 hours, becoming maximal at 48 hours and resolving approximately 96 hours after exposure (49).

The centrilobular nature of the

necrotic reaction suggests the participation of the microsomal xenobiotic metabolizing enzymes since this area of the liver lobule is
known to be rich in that type of enzymatic activity (48).
Experiments by Reid and Krishna (49) have made it clear that
MFO's are indeed involved.

Treatment of rats with piperonyl butoxide

of SKF 525-A before administration of bromobenzene blocked the necrotic reaction in vivo.

Pretreatment with phenobarbital in the absence

of MFO inhibitors had an enhancing effect on necrosis.
When covalent binding to proteins was the effect of interest
rather than actual necrosis, similar correlations were seen (53).

In

vivo binding was blocked by SKF 525-A and enhanced by induction with
phenobarbital.

The magnitude of protein binding was dose dependent.

Sephadex column chromatographic isolation of the protein bound radioactivity indicated that three proteins with molecular weights of
1500, 50,000 and 160,000 were involved.

Protein hydrolysis and

ligand exchange chromatography indicated that covalent binding occurred at cysteine, cysteic acid and at one unidentified amino acid.
The participation of glutathione in this process was also i nvestigated by this group (49).

Liver glutathione l evels were depleted by
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pr i or administration of diethyl maleate.

Subsequent dosing with 14C-

bromoben zene showed that this treatment accelerated the onset and
increased the severity of the centrilobular necrosis.

The concentra-

tion of covalently bound radioactivity in liver was found to have
been more than doubled after this pretreatment.
An indication of the events that account for these effects is
found in a study (54) in which it was shown that little covalent
binding occurred during the initial phase of 14 C-bromobenzene challenge while large amounts of mercapturic acid were formed.
of the glutathione was depleted,
binding occurred.

After 90%

however, considerable covalent

The conclusion was that glutathione exerts a

protective effect by decreasing the concentration of the hepatotoxic
metabolite.

This protective action on the part of glutathione has

al so been reported for the polycyclic aromatic hydrocarbons (vide
s upra) .
Inve stigation of the metabolism of the halobenzenes (54) led to
the dis covery of an epoxide metabolite formed by the action of the
MFO' s .

This epoxide was considered to be the activated metabolite

that participates in the binding reaction.

The finding by Krishna,

et al. (53) that this binding involved only three proteins sheds some
light on the possible mechanism by which the necrosis is brought
about and reinforces the conclusion that a specific biochemical
lesion is the cause.
Hepatotoxicity involving carbon tetrachloride.

Hepatic necrosis

as the result of mammalian exposure to carbon tetrachloride is probably the most widely studied of the hepatotoxic effects arising from
the halogenated hydrocarbons (55).

The topic has been extensively
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reviewed (50, 56).
The toxic action of carbon tetrachloride differs considerably
from that of the compounds considered so far.

Although activation is

by the MFO system and necrosis is the end result, this is where the
simi larity ends.

Carbon tetrachloride activation proceeds by a

series of reductive steps rather than by oxidation (24, 50).
The events following the activation of carbon tetrachloride are
the focus of some disagreement.

On the one hand are those who feel

that hepatic cell death arises as the result of radical formation and
subsequent lipid peroxidation and destruction of membrane integrity
(52, 56).

On the other hand are those who feel that necrosis is the

result of the interaction of a metabolically activated species with
tissue proteins (50).

Both circumstances have been studied and both

seem to correlate with the resultant necrosis.

Until more is known

about the specific causes of cell death the exact mechanism of the
necrogenic activity of carbon tetrachloride will remain in a state
similar to that of carcinogenesis.
There has been some disagreement in the past over what constitutes the si te of activation of carbon tetrachloride within the microsomal mixed-function oxidase system.

Slater (57) proposed that the

activation was catalysed by the enzyme NADPH-cytochrotie P-450
reductase upstream from cytochrome P-450 in the microsomal electron
transport system.

This speculation was probably based on the fact

that the metabolism was reductive rather than oxidative and has
stimulated considerable effort on the part of others.
Work by Sipes, eta!. (3) using tissue binding as a means of
measuring carbon tetrachloride metabolism, showed that covalent
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binding dropped when an in vitro system was pretreated with alylisopropylacetamide.

The decrease in binding was proportional to the

loss of cytochrome P-450 activity as established by measurement of a
reduced rate of ethylmorphine demethylation.

Under the effect of

alylisopropylacetamide, NADPH-cytochrome P-450 reductase activity
remains intact.

Work with cobaltous chloride and methyl mercury

hydroxide, which have a similar effect on cytochrome P-450 (cyt. P450), has given similar results (3).
In the same investigation, covalent binding to protein was shown
to be inhibited by a carbon monoxide atmosphere and the omission of
NADPH from the reaction mixture.

Antiserum specific for NADPH-cyt. P-

450 reductase reduced covalent binding in proportion to the inhibition of the reductase.

Ethylmorphine reductase activity was

reduced in the same proportion.

It now seems to be generally accepted

that the site of reductive, anaerobic, microsomal carbon tetrachloride
activation is at cyt. P-450 (3, 24, 50).
The mechanism of carbon tetrachloride activation.

The actual

mechanism by which carbon tetrachloride is activated appears to be
reductive dehalogenation by cyt. P-450.

Homolytic cleavage of one of

the carbon chlorine bonds under anaerobic conditions results in the
production of a trichloromethyl free radical (52).

This mechanism was

borne out by the discovery that carbon tetrachloride metabolism caused
enhanced microsomal lipid peroxidation with the formation of malondialdehyde in vitro (52).

Additionally, Uehleke, et al. (SO) have

described the destruction of cyt. P-450 during carbon tetrachloride
metabolism and covalent binding to proteins.

Both of the se phenomena

are felt to be the result of reductive radical production.
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Consideration of the products found to result from the anaerobic
metabolism of carbon tetrachloride, naturally, sheds some light on the
details of the mechanism.

Several studies have yielded reports of the

production of hexachloroethane (SO, and references therein).

The best

explanation for this is that hexachloroethane represents the termination product of a free radical chain (SO).

A second metabolite pro-

duced under these conditions is chloroform (50).

Its presence in in

vitro systems is also felt to be the result of the free radical
process.

The supposition is that chloroform is generated by the inter -

action of the trichloromethyl radical with the polyenoic lipids of the
microsomal membranes.

An electron is abstracted and lipid peroxida-

tion within the membranes is initiated (SO, 53).
It is characteristic of carbon tetrachloride metabolism in vivo
to produce a rapid loss of microsomal enzyme activity including cyt.
P-450.

Until recently, this had been interpreted to mean that P-450

is being destroyed directly by the action of free radicals on the
cytochrome itself or indirectly by their disruption of the membrane
matrix (52).

The latter point of view is supported by the fact that

the activity of other microsomal enzymes is also decreased during
carbon tetrachloride metabolism (52).

Wolf, et al. (24) have

reported that carbon monoxide is a product of anaerobic carbon tetrachloride metabolism in NADPH reduced microsomes.

This conclusion was

reached after the demonstration of carbon monoxide in post incubation
microsomal preparations.

Based on these observations and kinetic

evidence, this group has concluded that at least part of the loss in
cyt. P-450 activity is the result of carbon monoxide binding and
subsequent inhibition .
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Aerobic metabolism of carbon tetrachloride in microsomal systems
has been shown to give rise to phosgene (3) .

Phosgene is known to be

a product of chloroform metabolism as well (ibid.).

It could be, then,

that it is a secondary metabolic product of carbon tetrachloride arising as a result of chloroform production via free radicals.

The sug-

gestion has been put forward (3) that phosgene arises due to the rearrangement of trichloromethanol oxidatively produced by cyt. P-450
during chloroform metabolism .

Although phosgene is not a free radical

initiator itself, it does participate as a chlorinating and carbonylating reagent via a free radical mechanism after initiation of the
chain by other radicals (58).

Given this information, it is obvious

that pho s gene could also be participating in the production of hepatotoxicity caused by carbon tetrachloride.

Aside from trichloromethanol

and phosgene production, the oxidative metabolism of carbon tetrachloride is known to yield C0 2, certainly a detoxification product
(50, 52)

0

The identification of carbon monoxide as an end product plus the
known production of free radicals has led Wolf, et al. (24) to propose
a unique mechanism for the reductive metabolism of halogenated
methanes by cyt. P-450.

They have suggested that in the absence of

oxygen the halogenated alkyl compounds react directly with the
reduced iron in the heme group of the cytochrome.

Here they are

transformed by cyclic reduction with electrons from the nucleotide coenzymes via a carbene mechanism which ultimately yields carbon
monoxide.

In the case of carbon tetrachloride, for example , trans-

formation proceeds via the trichloromethyl radical to dichlorocarbene
which hydrolyses to give two halo acid molecules and carbon monoxide.
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This is feasible from an organic chemical point of view because
chloroform in the presence of base forms carbon monoxide via a dihalocarbene intermediate (58).
As with carcinogenesis, understanding of the events occurring
between cell damage and the appearance of the macroscopic lesion,
necrosis, has not progressed far beyond the point of supposition.
exact chemical lesion has not yet been agreed upon.

The

So the question

as to how carbon tetrachloride actually initiates its characteristic
centrilobular necrosis must await additional work before it can be
completely resolved.
Drug induced blood dyscrasias
One final pathological condition that must be discussed in this
context is the aplastic anemia that develops in a small number of
those that are therapeutically exposed to the antibiotic chloramphenicoll (59).

Only one case in forty thousand is afflicted with this

fatal condition but reports of similar dyscrasias resulting from
exposure to chlordane suggest that this lesion might fall into the
category of those caused by organic chemicals that exert their toxic
effects after metabolic activation (6, 19).
Chloramphenicol has been used as an effective treatment in a wide
variety of bacterial infections.

However, due to the fatal side ef-

feet, its usefulness has now been limited to particularly virulent
infections or to cases where no other antibiotic offers adequate
protection against an otherwise fatal disease (59).
1Ch loramphenicol; (lR, 2R)-(+)-1-p-nitrophenyl-2-dichloroacetamido-l, 3-propanediol.
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The metabolic activation of chloramphenicol.

Work by Pohl and

Krishna (60) with 14 C-chloramphenicol showed that metabolic activation in vivo and in vitro results in the covalent binding of radioactivity to tissue proteins.

This binding was shown to be enhanced by

pretreatment with phenobarbital.

This evidence, coupled to the fact

that in vitro incubation under N2 or carbon monoxide atmospheres,
exclusion of NADPH or treatment with SKF 525-A inhibited binding (61),
indicates that this is another case in which a cyt. P-450 mediated
activation gives rise to a compound that covalently reacts with tissue
proteins.
Identification of the covalently interacting metabolite.

Using

doubly labelled chloramphenicol, Pohl and Krishna (60) were able to
show that the entire molecule was participating in macromolecular
binding rather than a fragmentary metabolite.

Further, they were able

to eliminate the aromatic nitro group as the active site by testing
the binding capability of the trifluoroacetamide and unsubstituted
acetamide 1 analogues as well as dichloroacetamide itself.

Binding oc-

curred only in the case of metabolically activated dichloroacetamide
indicating that activation and binding were occurring at the dichloroacetamide end of the molecule.
Subsequent investigations (61), using acid and base hydrolysis
of chloramphenicol labelled protein and isolation of the drug protein
adduct, resulted in the identification of chloramphenicol oxamic acid
as the hydrolysis product.

This led to the proposal that

1Trifluoroacetamide analogue; (IR, 2R)-l-p-nitrophenyl-2-trifluoroacetamido-1,3-propanediol. Unsubstituted acetamide analogue;
1-p-nitrophenyl-2-acetamido-1,3-propanediol.
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chloramphenicol is activated by microsomal hydroxylation of the
chlorinated amide carbon.

This, in turn, rearranges with the loss of

HCl to an oxamyl chloride which reacts with protein at an 0, S or N
atom or hydrolyses to chloramphenicol oxamic acid.

The proposed path -

way is given in figure 3.
The Biochemistry of the Microsomal
Xenobiotic Metabolizing System
The microsomal mixed-function oxidases
In addition to performing the bioactivations discussed in the
preceeding section, this group of enzymes has been shown to be involved in the transformation of a variety of other exogenous and endogenous substrates appearing at or arising in lung, intestinal mucosa,
kidney and skin as well as the liver (62).

Endogenous compounds

include steroids, fatty acids, bile acids and heme (63).

Compounds

of exogenous origin include drugs, carcinogens, antibiotics, insecticides (63) and volatile anesthetics (25) as has been explained above.
The ability of enzymes in hepatic microsomes to metabolize
foreign compounds has been established for some time.

The first

report of this phenomenon occurred in 1949 with the discovery that an
enzyme in liver microsomes catalysed the reductive cleavage of aminoazo dyes (64) and their oxidative demethylation (65) .

Subsequent

work showed that a variety of reactions are catalysed by this
system.

As early as 1955, hydroxylation, deamination and ether cleav-

age had been recognized (66).

The list has now been expanded to

include aromatic hydroxylation, sulfoxidation, epoxide formation,
desulfuration and dehalogenation (63) as well.
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The proposed pathway for the liver microsomal activation
and protein binding of chloramphenicol.

A period of intensive study following the initial discovery of
the metabolic activity of hepatic microsomes led to the description of
the biochemical conditions necessary for maximal activity of the
enzymes.

Brodie, et al. (66) showed that aminopyrine demethylation

by liver microsomes was maximized by aerobic incubation in the
presence of NADP, an NADPH generating system and magnesium ions.
Additional study led to the knowledge that the activity of the
microsomal drug metabolizing system was increased by pretreatment with
barbiturates (67, 68).

This work by Remmer was the first report of

the now well-known inducibility of these enzymes.

Many compounds are

currently known to give rise to this phenomenon including 3-methylcholanthrene, DDT, chlordane and anabolic steroids (63).
It was not until the mid-sixties that the source of the microsomal drug metabolizing activity was shown to reside in a material
with the characteristics of a cytochrome (69) that had first been discovered in 1958 (70, 71).

This cytochrome was capable of binding
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carbon monoxide and gave a reduced versus reduced

+

carbon monoxide

difference spectrum with a characteristic peak at 450 nm (72).

As a

result, the material has come to be known as cytochrome P-450.
Enzymatically it falls into the category of external mixed-function
oxidases

in that it uses

of oxidized substrate and

mole of molecul ar oxygen to produce l mol e
mole of water (73).

The oxidative metabolism of drugs and foreign compounds is not
the only enzymatic activity that resides in liver microsomes.

A

second hemoprotein designated cytochrome b 5 (cyt. b 5) is also present.
This material was first reported in 1952 (74).

In fact, knowledge of

the presence of this cytochrome led to hesitancy in the initial identification of cyt. P-450 in rat and pig liver microsomes .

The feel-

ing was that cyt. b 5 might have been the source of the cytochromelike behavior in the liver microsomes that were under investigation
(70, 71).
Cyt. b 5 is now known to be involved in the elongation of saturated fatty acids that occurs in the microsomes.

It participates in

the desaturation of stearyl CoA and palmityl CoA to oleyl CoA and
palmitoleyl CoA respectively (75).

The terminal enzyme, in this case,

is not the cytochrome but an additional non-heme iron protein sensitive to the action of cyanide aptly named the cyanide sensitive
factor (76).

The source of reducing equivalents for cyt. b 5 is NADH.

However, desaturase activity can be maintained using NADPH (75).
Current thought on the sequence of microsomal electron transport
and the mechanism of action of cytochrome P-450
Elucidation of the sequence of liver microsomal electron t ransport from the pyridine nucleotide coenzymes to the terminal electron
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acceptors proved to be a thorny path for the researchers who chose to
investigate it.

Several factors peculiar to microsomal electron

transport contributed to the difficulties.

Primary among these was

the fact that the function of this electron transport system seems to
be one of distribution of reducing equivalents rather than the
productionofenergy as is the case in mitochondrial electron transport.

This results in a complicated circuit, in the electronic sense,

with multiple inputs and outputs and for which the path of electron
flow can be altered to fit the metabolic job at hand.

Secondly, and

more intimately related to the mechanism of action of cyt. P-450, has
been the problem of the origin and order of insertion of the electrons
reducing the cyt. P-450-substrate complex.

The solutions to both of

these problems have been partially worked out.
Definitive work on the nature of the sequence of microsomal electron transport to cyt. P-450 was frustrated largely because of the
membrane ' bound nature of the components.

This made them resistant to

solubilization in active form by classical means.
work progressed slowly.

As a consequence,

Lu, et al. (63, 77) have succeeded in

solubilizing and isolating cyt. P-450 and the membrane bound components of the associated electron transport system using detergent in
the presence of glycerol and separation on DEAE cellulose in the
presence of detergent.
Reconstitution experiments with the solubilized components have
shown that an active drug metabolizing system requires NADPH, a flavoprotein NADPH-cyt. P-450 reductase, cyt. P-450 and a lipid fraction
that has been shown to be phosphatidyl choline.

Lu has speculated

that the lipid facilitates the transfer of electrons from the

30
reductase to cyt. P-450 (63).
The nature of electron transport to cyt. bs during fatty acid
desaturation is similar to that seen with cyt. P-450.

A flavoprotein

is responsible for the tran sfer of electrons from NADH to cyt. bs and
has been termed NADH-cyt. bs reductase (78).

As mentioned above,

electrons are transferred from cyt. bs to the terminal desaturase , the
cyanide sensitive factor (76).
The situation, then , is one of two chemically parallel electron
transport chains involving two cytochromes that operate with maximum
efficiency using electrons from different sources.

The complexity

arises from the fact that there are points of crossover between the
parallel pathways.

This is reflected in the work of Mueller and

Miller in which the xenobioticmetabolizingactivity of liver microsomes was first described (64, 65).

They were able to demonstrate the

metabolism of 4-dimethylaminoazobenzene using both NADH and NADPH as
sources of reducing equivalents.

This is the case with many other

substrates of cyt. P-450 as well; i.e., 3,4-benzpyrene (79), laurate
(80), and 0-ethyl-0-(4-nitrophenyl) phenylphosphonothioate (81).

In

most cases, though, NADPH is the more efficient electron donor with
NADH supporting a lesser rate of transformation (82).
ha s also been shown to occur.

The converse

The 9-desaturation of stearyl CoA,

known to be an NADH-cyt. bs mediated process, proceeds just as effectively with NADPH as the electron donor (78).
West, et al. addressed the crossover problem as it applies to the
hydroxylation of 3,4-benzpyrene and the N-demethylation of benzphetamine, both of which are cyt. P-450 mediated reactions (82).

They

found that when these reactions were carried out in a reconstituted
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system with NADPH as the electron source, cyt. bs was not an obligatory
component of the electron transport chain.

However, when the NADH

supported hydroxylation of 3,4-benzpyrene was studied they found that
the reaction either ceased or continued at a very reduced rate when
NADH-cyt. b 5 reductase or cyt. b 5 was omitted from the reaction mixture.

In addition, they were able to show that the hydroxylation of

benzpyrene in this system was uneffected by concentrations of
cyanide known to inhibit the 9-desaturation of stearyl-CoA confuting
the participation of the cyanide sensitive factor in this reaction.
These results have led this group to suggest the pathway shown in
figure 4 to represent the partial sequence of microsomal electron
transport.

Figure 4.

Schematic representation of the partial sequence of
microsomal electron transport. Redrawn from (82).

Evidence from other work (78) supports this scheme for microsomal electron transport and adds an additional level of complexity.
The addition of organic peroxides to preparations of microsomes
causes the rapid oxidation of both cyt. b 5 and cyt. P-450.
peroxides are reduced to an alcohol and water.

The

The reaction is

catalysed by cyt. P-450 but proceeds with either NADH or NADPH as a
source of electrons.

The use of antibodies to cyt. b 5 and NADH-cyt.
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b s reductase have shown conclusively that both the cytochrome and the
reductase are required for the NADH supported reaction.

NADPH

dependent hydroperoxidase activity operates independentl y of cyt. b 5
and its flavoprotein reductase.

In fact, the addition of cyt. b 5 was

inhibitory in a reconstituted P-450 system metabolizing cumene hydroperoxide at the expense of NADPH.

Cyt. b 5 has also been shown to play

a part in the hydroxylation of laurate and chlorobenzene.
It seems, then, that in some cases cyt. P-450 mediated oxidations
proceed via electron flow through cyt. b 5 .

It is possible that

several cytochromes P-450 exist and that some of these are obligated
to accept electrons from NADH through cyt. b 5 as well as from NADPH.
The latter suggestion draws credibility from the fact that a different
MFO, cyt. P-448, is known to be induced by polycyclic aromatic hydrocarbons in rodents and is specific for their hydroxylation (79).
Additionally, electrophoretic studies have shown the presence of
multiple forms of cyt. P-450 (83).
The current view of liver microsomal electron transport, then, is
of a system supplied by electrons from both NADH

and NADPH.

These

el ectrons run along two interconnecting pathways to the point where
th ey are either directed to the cyanide sensitive factor or to one of
several terminal oxidases of the cyt. P-450 group.

The ultimate fate

of the electrons in the system is determined by the substrate at hand
and, presumably, by the state of induction of the tissue in which
these events are occurring.
The mechanism of cyt. P-450 catalysed reactions has been the
subject of intensive investigation since Omura, et al. showed that it
was the enzyme responsible for liver microsomal drug metabolism (84,
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85, 86, 87).

General agreement has been reached on the overall

sequence of events involved in the cyclic reduction and oxidation of
the cytochrome.
figure 5.

Basically, the sequence can be visualized as shown i n

The figure is a composite from the work of Coon (84) and

Estabrook (85).
Step A depicts the reaction of ferric cyt. P-450 with subs trat e .
This is a rapid reaction and, according to Coon (84) may or may not
precede the initial electron transfer as shown in the figure at step
B.

No matter what the sequence, the result of the transfer of an

electron from NADPH is the reduction of the cytochrome heme-iron to
the ferrous state.

Molecular oxygen joins in step C to give the

ternary ferrous cyt. P-450, substrate, oxygen complex.

It is at this

point that carbon monoxide can react with the cyt. P-450-substrate
complex to give the characteristic 450 nm absorption peak seen in the
ultraviolet difference spectrum.
electron transfer.

Step D represents an intermolecular

An electron is passed from the ferrous heme-iron

to the bound molecular oxygen yielding a bound superoxide anion and
ferric cyt. P-450.
It is generally agreed that from this point to the liberation of
oxidized substrate and water the reaction becomes concerted.

A second

electron, originating either from NADPH or from NADH via cyt. bs, is
transferred to the ternary complex.

Estabrook (85) feels that this

electron immediately rereduces the cytochrome iron as shown in the
figure at E.

(However, recent work by Coon ' s group (85, 86, 87)

indicates the possibility of another mechanism not shown i n the
figure.

This will be discussed be l ow.)

Reduction of the iron is

1~H
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The cyclic pathway of oxidation and reduction of cyt. P-450
during oxidative xenobiotic metabolism. Redrawn from
(84 and 85).

followed in concerted fashion by intramolecular electron transport to
give fully activat ed oxygen which attacks the substrate and simultaneously draws two protons from the medium to yield hydroxylated subStrate, water and oxidized cyt. P-450.
The controversy still surrounding this sequence involves two
main points.

As mentioned above, there is still confusion regarding

the origin of the second electron; the electron entering the cyc lic
reduction at e.

Additionally, there is still an argument involving

the form taken by molecular oxygen during its transient relationship
with iron as the activating electron transfer occurs.
text this is actually a moot point.

In this con-

For the sake of completeness,

however, it will be explained briefly.
Uncertainty over the electron transport sequence has its origins
in two areas.

Electron transfer from NADPH is known to involve two
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electrons (73) and stoitiometric work with cyt. P-450 has shown that
one mole of NADPH is indeed oxidized for each mole of water and oxidized substrate produced (84).

The transfer of electrons to cyt. P-

450, however, is a staggered sequential process passing through a
flavoprotein reductase.

Flavoproteins are known to be able to trans-

fer only one electron at a time (73).
The search for an explanation of how two electrons generated at
the same time can participate in sequential reductions has given rise
to the work on the crossover of electrons between the NADPH and NADH
pathways.

There does not seem to be much doubt that in some cases the

second electron comes from NADH via cyt. b .
5

This,

howev~r,

still

leaves the fate of both electrons from NADPH unexplained.
As indicated above, Coon's group have recently published work
that sheds some light on this problem (85, 86, 87).

Briefly, they

have been able to isolate cyt. P-450 and the flavoprotein reductase
in highly purified form from the liver of rabbits induced with phenobarbital.

The purified reductase has been shown to contain one

molecule of FAD and one molecule of FMN per protein chain.

This is

consistent with an earlier report of the same phenomenon (88).

The

presence of two flavins associated with one enzyme may partially
explain the problem of sequential transfer.

Under these conditions

the reductase has the capability, in theory at least, of accepting two
electrons.

This leaves only the sequential transfer of the two

electrons from the reductase to the cyt. P-450 to be rationalized.
In the same work (85, 86, 87) there is an indication that iron is
not the only electron acceptor on the cyt. P-450 molecule.

Experi-

ments with purified rabbit liver cyt. P-450 indicates the presence of
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a sulfhydryl electron acceptor.

The indication is that within cyt.

P-450 there is a two step intramolecular electron transfer.

In the

course of catalysis the second electron is passed from a redox active
sulfhydryl to ferric iron and then to oxygen.

This work is no cause

for the theory of second electron transfer from cyt. b 5 to be diecontinued, however.

The evidence for that mechanism as reviewed by

Schenkman appears to be too s trong (78).

The experimental evidence

probably should be interpreted to mean that it is entirely possible
for the second elec tron to arise by either mechanism and that the
ultimate determinate of the source of this electron may be the substrate at hand.
A final facet of this interesting problem involves the existence
of more than one form of MFO.

In their work with purified cyt. P-450,

Coon's group titrated their pure liver microsomal cytochrome with
dithionite and found that it accepted two electrons (86).

The exper-

iment carried out with purified cyt. P-450 from the bacterium P.
putida showed the uptake of only one electron per cyt. P-450 molecule
indicating a basic mechanistic difference between these two cytochromes (85).

Work mentioned above (83) has shown that multiple forms

of cyt. P-450 exist in liver microsomes.

It is very possible that one

or more of these forms depends on cyt . b 5 as a source for its second
electron.
The second area of controversy within the context of mechanism of
action of cyt. P-450 involves the transient form of oxygen during
second electron transfer and its attack on subs trate.

The confusion

surrounds whether oxygen-substrate interaction occurs before the
second electron is passed from ferrous iron to oxygen (while th e
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oxygen is still in the superoxide state) or after the transfer of the
second electron when a ferric hydroperoxide exists (85).
there is an additional possibility.

Actually,

Hamilton (89) has noted the

similarity between reactions involving carbene transfer in the transition state (carbenoid reactions) and the products of cyt. P-450
catalysed reactions.

The transfer of the active oxygen species has

been termed the oxenoid mechanism by analogy.

A case has been made

for the formation of an intraenzyme peracid as the source of the
oxene formed as the result of nucleophilic of iron bound peroxide on
an enzyme carbonyl.

These mechanistic areas of controversy will only

be resolved by future study as has been the case in other areas of
the chemistry of this highly complex group of enzymes.
Hepatic epoxide hydratase
A second source of hepatic microsomal xenobiotic transforming
activity lies in the enzyme cleaving the oxirane rings of epoxides,
hepatic epoxide hydratase (HEH).

This enzyme is responsible for the

hydrolytic production of trans-dihydrodiols from exogenous epoxides
and from epoxides generated from unsaturated compounds by the cyt.
P-450 system (26).

Like the MFO's, HEH has been implicated in the

activation of epoxides to forms which bind covalently to cellular
macromolecules (26, 38) and in the detoxification of epoxides
potentially harmful in their own right (90, 91).

Oesch and his col-

laborators are primarily responsible for the isolation and biochemical characterization of these enzymes (90-96).

The topic has been

reviewed in detail by Oesch (26).
HEH activity has been detected in all species tested.
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Furthermore, distribution is wide within the individual organism.
Activity has been found in liver microsomes from rat, mouse, pig,
guinea pig, rabbit, rhesus monkey (92) and humans (26).

In rat and

guinea pig, activity is high in liver, intermediate in kidney and
intestinal mucosa and absent in brain, heart, spleen and muscle (92).
Activity has been detected in skin from the mouse (97) and rat (98).
Investigation of the behavior of these enzymes indicated that
their activity is increased by pretreatment with a variety of organic
£ompounds.

Pretreatment of male rats with phenobarbital, 3-methyl-

cholant hrene and benzene gave mixed results.
HEH activity 230-270%.

Phenobarbital induced

Activity was increased to 120-145% of controls

with 3-methylcholanthrene while benzene caused no increase in enzyme
activity (99).

In an unrelated investigation, feeding 25 ppm

dieldrin was found to increase HEH activity to a maximum of 250% of
controls in rats (100).

Recent work has identified trans-stilbene

oxide as a potent and se lectiv e inducer of HEH giving levels of induction up to 300% of controls with no parallel increase in the activity
of the MFO's (101).

The increased activity, in this case at least,

was due to an increase in enzyme concentration rather than an activation of pre-existing protein .
a tempting one.

The analogy to the microsomal MFO's is

However, HEH has been shown to be under separate

genetic control (100) and HEH activity has been isolated free of the
MFO's (97).
Solubilization and purification of HEH from guinea pig liver
made biochemical characterization possible (94).

HEH activity was

found to reside in a protein distinct from squalene oxidocyclase
which is also found in liver microsomes (95).

Activity was
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independent of metal ions and NADPH and was uneffected by inhibitors
of the MFO's.

The enzyme was not inhibited by carbonyl reagents but

a slight and significant inhibition arose following tr eatment with
sulfhydryl reagents.

High substrate concentrations were inhibitory

while product concentration had no effect (27).

The pH optimum was

sharp at pH 9.0 (94).
The chemistry of the enzymatic cleavage of oxiranes was investigated using microsomal preparations and naphthalene-1,2-oxide as a
substrate (27) .

Attention to the origin of entering oxygen with

H2 18o showed that trans-dihydrodiol formation involved incorporation
18
of
0 at the 2-position of the naphthalene, leaving the oxirane
oxygen at carbon 1.

The product diol invariably had the trans-

configuration.
Further work with microsomes using naphthalene itself rather
than the 1,2-oxide has shown that oxygen from air is incorporated into the !-posi tion of the trans-dihydrodiol resulting from the ring
cleavage (27).

This result would be expected following epoxide forma-

tion by the MFO's.

As indicated above, the oxygen at the 2-position

originated with water.

The same was found to be true for the alkyl

epoxide formed from stytene providing proof of the intermediate
nature of the epoxide in the microsomal metabolism of these two compounds.
Involvement of epoxide hydratase in metabolism of the
ch lorinated cyclodiene insecticides
The way that HEH is involved in the metabolism of chlordane
itself is not yet clear.

The pathway for chlordane metabolism

proposed by Brimfield, et al. (102) assumes the participation of HEH
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but only on the basis of circumstantial evidence.

The conclusion

reached in their investigation, that oxychlordane is not a substrate
for HEH per se, is shared by Street and Blau (103).

They reasoned

that oxychlordane was a terminal storage residue at least in rats.
Some light is shed on thi s problem in the following discussion.
Work with the cleavage of the oxirane rings of chlorinated
cyclodienes such as dieldrin, endrin and heptachlor epoxide antedates
the investigations of Oesch, et al.

None of the following studies is

directly concerned with chlordane but the compounds above are close l y
related to chlordane and, in some cases, have been shown to arise
during chlordane metabolism (102).
Working with the epoxides of chlorinated cyclodienes and their
analogues, Brooks has shown that these compounds are transformed to
trans-dihydrodiols in preparations of mammalian liver microsomes
(90, 104).

Initially two compounds were studied (90).

The first,

HCE (VII, figure 6) is analogous to the insecticide dieldrin but has
no methylene bridge on the non-chlorinated cyclohexane ring.

The

second, chlordene epoxide (I, figure 6) is a six chlorine containing
analogue of heptachlor epoxide and oxychlordane.

Both HCE and

chlordene epoxide resemble the methanoindanes in that th ey are
asymmetric and they are presented to HEH as a racemic mixture.
The point of interest in this study was the action of pig liver
microsomes on these epoxides in the absence of MFO activity .

With no

NADPH added to the microsomal incubation system an optically active
trans-dial was produced repre sent ing roughly half of the racemic substrate added.
remained.

An unrnetabolized residue of optica ll y acti ve epoxide

Significant l y, metabolism in the form of epoxide ring
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cleavage ceased (HCE) or proceeded at a very reduced rate (chlordene
epoxide) when this point had been reached (90).
The optically active epoxides recovered from microsomal incubation had the same IR spectra after purification as the racemic mixture origina lly added.

Resubmission of the recovered purified

epoxides to microsomes in the absence of NADPH produced no significant metabolism in the case of HCE and a much reduced rate of metabolism in the case of chlordene epoxide.

Addition of NADPH yielded

oxidative metabolites of each of the recovered epoxides (90).
Since the stereoselectivity of the MFO's was not investigated,
any answer to the question as to whether or not a racemic mixture of
epoxide enantiomers is produced when non-epoxide starting materials
are employed remains speculative.

But work reported by Oesch with

naphthalene suggests that the epoxides are synthesized with low
stereoselectivity (25).

The pattern, then, seems to be production

of racemic epoxide enantiomers (or, at least, mixed enantiomer s) followed by stereoselective ring hydration to yie ld optically active
trans-diols and optically active residual epoxide.

Further epoxide

metabolism then proceeds by oxidative mechanisms.
This phenomenon was studied in greater detail in a subsequent
investigation (104).
lined above.

The results confirmed Brooks' earlier work out-

The action of pig, rabbit and rat liver microsomes on

racemic epoxides in the absence of NADPH produced optically active
trans-diols and residual epoxides.

There were two main points made

in the second investigation that are of interest here.

The effect on

epoxide ring hydration of exo and endo epoxide groups in the context
of the methanoindanes and the effect of increasing cyclopentane ring

43

chlorination on this process were established.
Four compounds were employed as substrates for microsomal
preparations.

Two stereoisomeric chlordene epoxides (I

6) and two stereoisomeric heptachlor epoxides (V
used.

&VI,

& II,

figure

figure 6) were

The result of the microsomal metabolism of chlordene exo-

epoxide (I, figure 6) was the same as that seen in the previous study.
An optically active trans-diol of chlordene (III, figure 6) was
produced.

The hydroxyl groups were 2 endo, 3 exo indicating attack

at the least sterically hindered 2-position by OH

When the endo

epoxide of chlordene (II, figure 6) was submitted to microsomal
metabolism two trans-diols were found.

The major metabolite was

2-exo-3-endo-hydroxy (IV, figure 6) indicating OH
at the 2-position.

attack from above

The minor trans-diol was 2-endo-3-exo (III,

figure 6), the same configuration seen in the metabolite of exochlordene epoxide.

In the cases of both the endo and exo-chlordene

epoxides chemical hydrolysis produced the same compounds as did
hepatic microsomes with the same quantitative relationships.
When the experiment was repeated using the stereoisomeric heptachlor epoxides the results were similar.

The exo-epoxide yielded one

trans-diol and the endo-epoxide gave two.

The interesting point that

arose during the course of this experiment was that the heptachlor
epoxides were much more resistant to enzymatic hydroly sis than the
simpler chlordene epoxides.

Additionally, the major metabolite of

the endo-epoxide was a 2-endo-3-exo-trans-diol (IX, figure 6) which
is the opposite configuration to that found with the endo-chlordene
epoxide.

Obviously, the chlorine at position 1 of the endo-heptachlor

epoxide directs OH

attack to the 3-carbon instead of to carbon 2 as
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was the case with the chlordene epoxide.

Again, chemical hydrolysis

of the heptachlor epoxides produced the same results as those found
using microsomes.
Brooks concluded from this work (90, 104) that epoxide hydration
effectively competes with post epoxide oxidative metabolism for the
favored enantiomer of these asymmetric pairs.

He also concluded

that the epoxide hydrolysing enzymes were more stereoselective than
the oxidative enzymes.

This stereoselectivity was found in microsomes

from the pig, the rabbit and the rat although the rabbit and rat
enzymes were much more sluggish than those from the pig.
Brooks further concluded that the facility with which the
epoxide hydratase enzymes transform the methanoindane cyclodiene
epoxides is effected by the bulk of the hexachloronorbornene nucleus
and its proximity to the sites of enzymatic attack.

This steric

effect i s modified by increasing chlorination of the cyclopentane
portion of the molecule.

Increasing chlorination directs epoxide

hydratase attack toward those sites more sterically hindered by
proximity to the hexachloronorbornene nucleus and slows the process
of epoxide cleavage considerably.
When these concepts are applied to considerations of the 8
chlorine containing oxychlordane it is small wonder that no transdiol of this compound has appeared in investigations of chlordane
metabolism.

The work of Brooks supports the view that oxychlordane

is a terminal residue (103).
Mammalian Biotransformation of Chlordane
One of the prerequisites for the study of xenobiotic
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transformation is, of course, that the starting materials be as pure
and homogeneous as possible.

In the study of chlordane metabolism

this has meant the use of pure chlordane rather than the technical
mixture that results from commercial chlordane synthesis.

Since

chlordane is made up of two isomers, metabolic studies have routinely
been carried out in parallel using pure cis-chlordane and pure trans chlordane .

Interestingly, the indications have been that the metab-

olism of the two isomers differs qualitatively (102, 105) and quantitatively (105, 106) both in vivo (105, 106) and in vitro (102).
One of the significant manifestations of these differences has
been found in the production of the epoxide metabolite oxychlordane
(V, figure 7).

Street and Blau (103, 107) exposed pure cis and trans-

chlordane isomers (I, II, figure 7) to metabolism by liver post-mitochondrial supernatent from rats pretreated with DDT.

They were able

to measure the recovery of unmetabolized parent compounds and two
metabolites, the epoxide and dichlorochlordene (IV, figure 7) gas
chromatographically.

The results showed that 37 . 7% of the trans-

isomer was converted to oxychlordane while only 14.1% of the cisisomer underwent this conversion.

Measurement of the recovery of

the unmetabolized parent compounds showed that 39% of the tran schlordane remained indicating that most of it had been transformed
to the epoxide.

Only 18% of th e cis-isomer was left unaltered leav-

ing a large portion of the metabolized material unaccounted for.
Based on this they concluded that although both isomers are oxidatively metabolized to the epoxide, a larger portion of the re sultant
epoxide metabolite arises from trans-chlordane than from cis.

They

also reached the conclusion that metabolic paths other than epoxide
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Figure 7.

The proposed routes for cis- and trans-chlordane
metabolism by rats in vivo. The solid lines indicate
the active routes and the broken lines represent weak
metabolic routes. The thickness of solid lines
indicates relative metabolic activity. Adapted from
(106).
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formation account for roughly 70% of cis-chlordane metabolism and
only 20% of the transformation of trans-chlordane.

Additional work

has confirmed these conclusions (105, 108).
The results of Street and Blau also led them to propose a metab olic route for the production of oxychlordane from either of the
isomers through the common unsaturated intermediate dichlorochlordene
(107).

One experiment showed that rabbit liver performed the chlor-

dane to dichlorodene conversion with less facility than rat liver in
vitro but was equally capable of converting preformed dichlorochlordene to the epoxide.

Based on this, they proposed that the desatura-

tion was the rate limiting step in oxychlordane production.
Evidence from several studies (103, 105, 109) indicates that the
epoxide metabolite oxychlordane is a terminal fat storage residue of
chlordane rather than a metabolic intermediate.

In vitro work (103)

showed no significant degradation of oxychlordane when it was exposed
to the action of rat liver homogenate.

No oxychlordane was found

in the feces of rats fed either a 25:75 mixture of trans- and cisisomers or the pure isomers alone although other metabolites were
present (109).

In a related study, however, animals given a single

oral dose of this epoxide excreted it intact in feces.

Balba and

Saha (105) isolated no oxychlordane from the urine of rabbits fed
radio labelled pure isomers.

But fat analysis in conjunction with

this study confirmed the earlier work of Street and Blau (107)
showing that more oxychlordane was produced from trans-chlordane
than from the cis-isomer and that this dichotomy was reflected in
the amount of epoxide found stored in fat.

An explanation for t his

difference in relative amounts of epoxide product have had to await
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the application of more sophisticated analytical techniques.
Direct evidence for pathways other than epoxide production
The extent to which oxidative metabolism contributes to chlordane biotransformation by paths other than epoxide production became
further evident with the report of hydroxylated metabolites found in
the urine of rabbits fed 14 C-labelled trans-chlordane (110).
compounds were found.

Two

One was identical to one of the two chloro-

hydrins derived synthetically from chlordene (XIII, figure 8).

Based

on the polarity it exhibited during thin layer chromatography, this
compound was assigned the structure 1-hydroxy-2-chlorodihydroheptachlor (VII, figure 7).

Brooks (107), reviewing an earlier descrip-

tion of this work, concluded on steric grounds that this compound
would have an exo-hydroxyl group.

The second metabolite was

thought to be 1,2-dihydroxydihydrochlordene (XVII, figure 8) although
confirmat ion of this was not pursued.

It was assumed that this diol

was the product of the hydrolytic removal of both chlorines.
Similar compounds have been identified in two additional studies
involving metabolism of chlordane in different systems.

Barnett and

Dorough (109) identified a hydroxylated dihydroheptachlor with a 1chloro-2-hydroxy configuration (VII, figure 8) as a component in
extracts of the feces of rats fed a mixture of 75% cis-chlordane and
25% trans-chlordane.

Configuration, in this case, was based on com-

parison with the behavior of a reference sample with the same structure.

Acetylation of the experimental material showed that it con-

sisted of equal concentrations of two compounds.

The second corre-

sponded to a minor component of the acetylated reference sample.

This
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Figure 8.

The proposed routes of metabolism for cis- and transchlordane in microsomal preparations from induced rat
liver. Structure I-II represents the complete cisand trans-chlordane molecules. Metabolites are shown
only as the five-membered portion of the molecule with
the hexachloronorbornene nucleus understood. Metabolites
proposed, but not actually found in this or other work,
are designated with a question mark(?).

so
s econd compound could be identical to the 1-hydroxy-2-chloro metabelite found in the work of Poonawalla and Korte.

Brimfield and

Street (108) identified the 1-chloro-2-hydroxydihydroheptachlor (VII,
figure 8) as a metabolite of trans-chlordane formed by rat liver postmitochondrial supernatant.

Structural determination, in that case,

was based on thin layer chromatographic comparison with a synthetic
standard characterized by nuclear magnetic resonance.
Additional light has been shed on the metabolic fate of chlordane
exclusive of the dichlorochlordene to oxychlordane conversion by the
work of Barnett and Dorough (109) .

Although they made no attempt to

outline a pathway to account for their results, they were able to
partially characterize four previously unreported metabolites of
chlordane.

These compounds were a hydroxylated chlordane (III,

figure 8), a dihydroxydihydroheptachlor having a molecular weight of
404 (X, figure 8), the cis- and/or trans-diol of dihydrochlordene
(XVII, figure 8) and a triply hydroxylated dihydrochlordene (XX,
figure 7).

Excreted conjugates of hydroxychlordane and the trihy-

droxy species were also observed, which constituted the first report
of chlordane generated conjugates.
The results of the work of Poonawalla and Korte (110), Barnett
and Dorough (109) and Brimfield and Street (108) lend further credibility to the conclusion reached by Street and Blau (107).

Consider-

able oxidative metabolism of both chlordane isomers occurs exclusive
of epoxide formation.
The overall pathway of chlordane metabolism:
of in vitro and in vivo investigations
The in vitro investigation.

comparison

The possibility of finding a
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mechanistic explanation for the production of different amounts of
oxychlordane from cis- and trans-chlordane isomers led Brimfield, et
al. to restudy the primary hepatic metabolism of these isomers in
vitro (102).

It was felt that working in vitro would help to elimin-

ate the uncertainty that often arises in establishing the origin and
mode of production of metabolites due to the effects of digestive
tract physiology and microflora.
The results of this work led to the proposal of the pathway
shown in figure 8.

The pathway was an attempt to explain the metab-

olic dichotomy with respect to oxychlordane production found by
Street and Blau in a manner consistant with this and previous work on
cyclodiene metabolism.
Briefly, it was proposed that a molecule of chlordane can follow
one of three courses during hepatic microsomal metabolism.

It can be

hydroxylated at the 3 position to give hydroxychlordane (III, figure
8), presumably prior to conjugate formation per (109).

Alternatively,

desaturation to dichlorochlordene (IV, figure 8) can occur followed
by the formation of oxychlordane (V, figure 8).

Or, finally, it can

proceed through reductive dehalogenation to give metabolites with
increasingly fewer chlorines on the cyclopentane ring (VI and XI,
figure 8).

These dehalogenated molecules can then participate in the

pathways of hydroxylation or desaturation and epoxidation that parallel the formation of dichlorochlordene and oxychlordane from chlordane.

The major route taken by a given chlordane isomer is probably

determined by whether the chlorine at position 2 is exo (cis) or
endo (trans) .

The trans-isomer is predominately desaturated or

hydroxylated while the cis-isomer is dehalogenated as its major mode
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of biotransformation (102).
An additional metabolic transformation indicated by the scheme
in figure 8 is the hydrolytic cleavage of epoxide rings by HEH.

As

mentioned above, this reaction has been shown to be stereospecific
always yielding trans-dihydrodiols and is independent of molecular
oxygen and NADPH (104, 111).

No evidence was found in this work to

indicate an interaction of HEH with oxychlordane .

However, the

induction of rats with a 25:75 (w:w) of trans- and cis-chlordane
caused an increase in microsomal HEH activity (112).

Additionally,

the cleavage of heptachlor epoxides, chlordene epoxide and the epoxides of various of the methanonaphthalene derivatives is well
documented (104, 111).

The finding of a dihydrodiol of heptachlor

(X, figure 8) from cis-chlordane (102) as well as the report of a
six-chlorine containing dial from the work of Barnett and Dorough
(109) provided evidence that HEH may be involved in chlordane metabolism at some level other than that of oxychlordane where it seems
to be inactive.
The in vivo investigation.

The most current investigation of

the metabolism of pure cis- and trans-chlordane isomers to be found
in the literature is that of Tashiro and Matsumura (106).

This was

an in vivo study using rats in which a small amount of confirmatory
in vitro work was carried out.

The research included feeding pure

chlordane isomers and collecting urine and feces for metabolite
recovery, qualitative identification and quantitation, the determination of relative excretion rates using

14C-labelled

cis- and trans-

ch lordane and, finally, the determination of the relative insecticidal activity of isolated metabolites using a mosquito larvae
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bioassay.
The conclusions reached as a result of this investigation are in
general agreement with the proposals of Street and Blau (103, 107) and
the results of the in vitro
(108).

meta~olism

work of Brimfield

and Street

They found that while both cis- and trans-chlordane are metab-

olized to oxychlordane via the common intermediate dichlordene, more
oxychlordane was generated in the metabolism of trans-chlordane.
Tashiro and Matsumura also found that the major metabolic route for
cis-chlordane involves forms of oxidative metabolism other than epoxide formation leading to more complete metabolism of cis-chlordane and
a higher excretion rate for cis-chlordane derived material.

Agreement

between this investigation and the study of Brimfield,et al. (102)
lies in the identification of heptachlor as a chlordane metabolite.
The result s of this in vivo work were incorporated into a proposed
pathway for the biotransformation of the chlordanes in rats.

This

pathway i s reproduced in figure 7.
In spite of the general agreement between the in vitro work of
Brimfield,et al. and this in vivo investigation, correlation breaks
down to some extent when the details of the two pathways are compared.
Specifically the sequence of events proposed to account for the
various metabolites identified is considerably different.
The identification of a hydroxylated chlordane as a metabolite
of trans-chlordane in the in vitro paper (102) marks a major departure
from the Tashiro and Matsumura pathway.

This compound was neither

among the direct metabolic products identified from extracts of urine
and feces or the aglycones generated as a result of the action of
a-glucuronidase on isolated glucuronide conjugates from the in vivo
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work.

Based on the results of Barnett and Dorough this might have

been an expected source of the hydroxylated chlordane (109).

Brim-

field,et al. felt that the fact that this material arose as a product
of the metabolism of trans-chlordane only made mechanistic sense
from the point of view that the relatively facile desaturation of the
trans-isomer indicates a tendency toward oxidative metabolism not
shared by cis-chlordane.

They were not able, unfortunately, to back

up this point of view with the results of Barnett and Dorough because
the latter did not study the metabolism of pure isomers but used a
mixture.

The absence of hydroxy-chlordane in Tashiro and Matsumura's

investigation may be explainable on the basis of hepato-biliary
circulation of this metabolite or its conjugation product leading
to "remetabolism" and excretion as the dihydroxy or trihydroxy
chlordenes.

Both of these compounds were identified (106).

Significantly, the production of heptachlor or a heptachlor-like
substance is reported in both the investigations (VIII, figs. 7
leading to the offering of overall pathways of metabolism.

&8)

Tashiro

and Matsumura found that heptachlor arises as the result of the
metabolism of both cis-chlordane and trans-chlordane.

Brimfield, et

al. detected it only in extracts of the microsomal metabolism of
trans-chlordane although they indicate the probability that it arises
as the result of the metabolism of both isomers in the pathway.

The

point of contention with respect to heptachlor production, in the two
metabolic schemes , is where it arises in overall chlordane metabo l ism.
Tashiro and Matsumura have placed heptachlor in the position of
a terminal residue undergoing no additional metabolism (fig. 7).
Brimfield, et al. on the other hand, speculate that heptachlor
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belongs in the position of a metabolic intermediate (fig. 8).

In the

course of their study Tashiro and Matsumura subjected the heptachlor
isolated from in vivo metabolism to metabolism by rat liver postmitochondrial supernatant.

Their results show only the production

of a small quantity of 1,2-dihydroxy-dihydrochlordene although this is
not reflected in the final pathway.

It is undoubtedly this dearth of

metabolic products that led them to place heptachlor in a terminal
position.

The literature shows that heptachlor is, indeed, a meta-

bolically labile compound both in vivo (113) and in vitro (114) yielding heptachlor epoxide and a hydroxy epoxide.

Neither Brimfield, et

al. or Tashiro and Matsumura found that these compounds arise during
the metabolism of chlordane.

But it is possible that a heptachlor

expoxide does arise as a result of chlordane metabolism and is rapidly hydrolysed to the diol or converted to the hydroxy-epoxide and then
bound to tissue macromolecules in the manner of the hydroxy-epoxides
formed from the carcinogenic polycyclic aromatic hydrocarbons (38) .
The report by Brimfield, et al. (102) of a dihydrodiol of heptachlor
from the metabolic transformation of cis-chlordane and the production
of a 6 chlorine containing diol in the in vivo investigation by
Barnett and Dorough (109) support the former point of view.

The

binding theory may have some merit, though, in the light of a report
of the carcinogenic activity of heptachlor in mouse liver as the
result of feeding heptachlor (115).

This is clearly an area where

further work is called for.
The report of Brimfield, et al. (102) of a cis-chlordane derivative with a fully saturated cyclopentane ring having only 1 chlorine
(VI, figure 8) marks another point of disagreement between the result

56
of the in vivo and the in vitro investigations.

There is no prece-

dent for this type of metabolic product in any of the studies of
chlordane metabolism under discussion here.

This, in fact, may be the

kind of easily overlooked detail on which a case can be built for
studying metabolism both in vivo and in vitro before drawing conclusions about metabolic phenomena.

The obvious conclusion is that this

compound does not show up in urine or feces.
The assumption from the presence of this metabolite in the in
vitro system was that reductive dehalogenation is involved in the
hepatic metabolism of the chlordanes; primarily the cis-isomer (102).
Although this is at odds with the results of the in vivo studies, it
is not an entirely novel suggestion.

For example, it has been known

for some time that DDT is converted to its reduced dehalogenated
derivative DDD in rat liver homogenate (116).

Recently, Lay, et al.

(117) described the reductive dechlorination of the aldrin metabolite
dihydroaldrin dicarboxylic acid in liver microsomes.

Although

Tashiro and Matsumura did not find this metabolite per se, a glance
at their pathway indicates that dehalogenation is one of the dominant
modes of cis-chlordane metabolism (IV, V, VII, figure 7).
Confirmation of these results of Brimfield, et al. will have to
await additional in vitro work.

For the time being, however, the

obvious conclusion is that the dihydroheptachlor (VI, figure 8) is
rapidly and completely converted to other metabolites so that it does
not appear in urine or feces.

Nhat has been presented here, then, has been information concern-
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ing the metabolism, molecular mode of action and symptomology of a
widely disparate group of compounds.

The characteri stic that is

shared by all of them is that they cova lentl y interact with tissue
macromolecules after metabolic activation to produce pathological
conditions in mammals.
Chlordane has now been shown to produce cancer in rodents and,
epidemiologically, to be associated with various anemias and cancers
in humans that resemble the conditions produced by chloramphenicol
and the polycyclic aromatic hydrocarbon carcinogens.

It has, as well,

been shown that chlordane is acted upon by the same enzyme systems
that are responsible for the metabolic activation of many of the
carcinogens, the necrogens and chloramphenicol.

Additionally, the

transformation of chlordane seems to proceed by similar mechanisms.
Evidence that chlordane participates in covalent binding to
cellular macromolecules has, so far, been lacking.

This leaves some

doubt whether chlordane fits the activation-binding-effect model
shown for the other compounds.

The results of the dissertation work

presented here help to dispel that doubt.
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STATEMENT OF THE DISSERTATION PROBLEM
Research Objectives
This investigation was undertaken to determine whether or not
chlordane interacts covalently with various cellular macromolecules
during hepatic microsomal metabolism.

Upon finding covalent inter-

action, the objective was to sufficiently characterize its biochemical
detail to allow a comparison of chlordane with other chemicals whose
toxic action seems to depend on macromolecular binding.

This aspect

of the investigation included a determination of the effect of
various pretreatments on MFO and HEH induction and a brief look at the
interaction of oxychlordane with HEH.

The hope was that work such as

this would allow the formation of conclusions about how chlordane
binding to macromolecules comes about and by analogy to other carcinogens, what the expected consequences of this binding would be.

Work

such as this will help direct future research into the significance of
chlordane as a long lived environmental contaminant.
The intended comparisons were to the polycyclic aromatic hydrocarbons and the halogenated methanes.

These groups are known to be

metabolized in microsomes to forms which interact covalently with
cellular macromolecules.

The details of the interaction have been

well characterized in the cases of these two groups and the reactions
have been correlated with cancer and centrilobular hepatic necrosis
respectively.
A third objective was the determination of whether an isomeric
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preference was at work.

Did cis-chlordane metabolism produce a

greater concentration of covalently bound material than trans-chlordane or vice versa?

This was an important question based on the

evidence for qualitative differences in the mechanism of metabolism
of cis- and trans-chlordane.
Late in the work an additional objective was included.

A

National Cancer Institute study showed that chlordane was a liver
carcinogen in the mouse but not in the rat.

Based on the equivocal

nature of the results from the rat experiments it was felt that the
mouse might be a more sensitive organism and yield more clear cut
results.

At this point, then, the experimental species was changed

and this change has permitted the drawing of some conclusions about
the correlation between in vitro studies of binding behavior and the
production of cancer in whole animals.

This situation may represent

a model for the study of species specific toxicity; i.e., the
tendency of different species to develop different pathological
lesions when confronted with the same toxic compound.

60

MATERIALS AND METHODS
Animals and Materials
Animals
Male Sprague-Dawley rats (Simonsen Laboratories, Gilroy, Ca . )
were used in the experiments involving the rat and male C57 black/
6J Fl hybred mice (same source) in the mouse work.

Weights of the

animals at the beginning of an experiment were 100-120 g for the rats
and 20 g for the mice.
Feed additives and feed
The pure cis- and trans-chlordane (1-exo, 2-exo, 4,5,6,7,8,8octachloro-3a,4,7,7a-tetrahydro-4,7-methanoindane and 1-exo, 2 endo,
4,5,6,7,8,8-octachloro-3a,4,7,7a-tetrahydro-4,7-methanoindane) added,
individually or as a mixture to the experimental feed, were analytical
reference standards of defined purity given to us by the Velsicol
Chemical Co., Chicago, Ill.

The cis-isomer was 100% by infrared

spectrometry and the trans-isomer was 99.8% pure as checked at the
source by the same method.

Both were recrystallized from benzene and

analyzed by electron capture gas chromatography before use.
chlordane contained no electron capturing contaminants.

The cis-

The trans-

chlordane appeared to be contaminated by a small quantity of heptachlor (less than 1%) as established by gas chromatographic retention
time.

Phenobarbital, used as an inducer, was USP grade and was ob-

tained from a local pharmacy.
The feed used for both experimental and maintenance diets was
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Lab BloFP (Allied Mills, Inc., Chicago, Ill.).

During maintenance

periods this was used as received in pelleted form.

For experimental

purposes, the pellets were ground into a coarse powder.
Reagents and biochemicals
Enzyme substrates and inhibitors.

The

14 C-labelled

cis-rich

chlordane used as a substrate for microsome preparations during the
methods development work and in the initial experiments was a gift of
the Velsicol Chemical Co.

This was a mixture of 25% trans-chlordane

and 75% cis-chlordane uniformly labelled on the norbornene nucleus.
This material had a specific activity of 10.9 mC/mMole and was made
available as a 7.52 mg samp l e representing 0.2 mC.
Thin-layer chromatography of this mixture showed a halogenated
contaminant with an Rf below that of cis and trans-chlordane.
not determined whether this spot was radioactive.

It was

An attempt at addi-

tional purification by neutral alumina column chromatography with
electron capture gas chromatographic monitoring of the column effluent
was carried out.

No substantial change in the gas chromatographic

profile of the mixture was seen after passage through the neutral
alumina column.

No further purification was attempted due to the fact

that additional quantities of this labelled chlordane were no longer
available.
Pure samples of uniformly ring labelled 14 c-cis-chlordane and
14 c-trans-chlordane were also used in this work.

Like the cis-rich

mixture mentioned above, these were a gift of the Velsicol Chemical Co .
The pure

14 C-cis-chlordane

had a specific activity of 10 .9 mC/mMole

and consisted of 1.88 mg dissolved in benzene with a total ac t ivity of
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0.05 mC.

The

14 c -trans-chlordane

had a specific activity of 6.26 mC/

mMole and consisted of 3.27 mg dissolved in benzene with a total
activity of 0.05 mC.

These were available in very limited quantity

and were again irreplaceable so no additional purification was
at tempted.

Thin-layer chromatography showed no detectable halogenated

contaminants in either sample.
Oxychlordane (1,2,4,5,6,7,8,8-octachloro - 2,3 -exo-epoxy-2,3,3a,4,
7,7a-hexahydro-4, 7-methanoindane) analytical reference grade, used in
the methods development work and as a gas chromatographic standard was
a gift of the Velsicol Chemical Co.

This material was of 98% purity

as tested at the source.
Tritiated styrene oxide, the mat eria l used as substrate in the
assay of hepatic epoxide hydratase activity, was purchased from New
England Nuclear Corp., Boston, Mass.

The specific activity as

received was 15.5 mC/mMole in a sample containing 6.71 mg.

For use

as a substrate in the enzyme assay, this material was diluted with
unlabelled styrene oxide (ICN, K&K Laboratories, Inc., Plainview, N.
Y.) that had been purified by vacuum distillation.

The activity as

used (labelled+ unlabelled styrene oxide) was 0.036 mC/mMole.

This

provided 110,000 dpm in 1.4 micromole/sample.
Aminopyrine used as a microsomal substrate to evaluate microsomal demethylase activity was purchased from Matheson, Coleman and
Bell Corp., Norwood, Ohio.

This material was used as received with

no further purification.
Trichloropropene oxide (TCPO) (1,2-epoxy-3,3,3-trichloropropane)
(Aldrich Chemical Co., Milwaukee, Wis.) was vacuum distilled before
use.

This was used to inhibit the activity of hepatic epoxide
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hydratase in those parts of the work where the metabolism of chlordane
without epoxide cleavage was of interest.
Other biochemicals.

Ribonucleic acid from calf liver, deoxyribo-

nucleic acid from calf thymus (DNA), nicotinamide adenine dinucleotide
phosphate (NADP).

D-glucose-6-phosphate (G-6-P), ribonuclease A.

glucose-6-phosphate dehydrogenase (G-6-PDH) and bovine serum albumin
were obtained from Sigma Chemical Co., St. Louis, Mo.

Calf thymus DNA

was deproteinized before us e by the method of Kay, et al. (118).
Chemicals used in scintillation counting.

PPO (2,5-diphenyloxa-

zole) and POPOP [1,4-bis-2-(4-methyl-5-phenyloxazoylbenzene)] scinti llation grade, were purchased from Packard Instrument Co., Downers
Grove, Ill.

Naphthalene, reagent grade, was obtained from J. T. Baker

Chemical Co., Phillipsberg, N.J.
and An-Ti-Sol

I~ and

Tissue solubilizers An-Ti-Sol

~

the detergent Triton X-lo&IDwere purchased from

ICN Radiochemicals Division, Irvine, Ca.

Solvents used in the scin-

tillation counting mixtures were obtained from normal sources and
were reagent grade or better.
Materials for the colorimetric assay of nucleic acids.

Diphenyl-

amine, used in the determination of DNA concentration, was obtained
from the Aldrich Chemical Co., San Leandro, Ca.

This was recrystal-

lized before use according to the method of Schneider (119).

Glacial

acetic acid used in thi s procedure was purified to remove carbonyl
impurities by refluxing over excess KMn0 4 for 1.5 hours and then
distilled.

The concentrated H2S0 4 used was Fisher A-3o&ID suitable for

cholesterol analysis (Sargent-Welch Scientific Co., Denver, Colo.).
This was the only grade of H2S0 4 that was found to be suitable for
this method .

Others caused the formation of a precipitate when mixed
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with the other component s of the color reagent.

Acetaldehyde was ob-

tained from the Aldrich Chemical Co., Milwaukee, Wis. and was redistilled before use.
Orcinol (3,5-dihydroxytoluene) used in the determination of RNA
ribose was purchased as technical grade from Eastman Organic Chemicals,
Rochester, N. Y.

This material was recrystallized three times (119)

before a usable white crystalline product was obtained.

Concentrated

HCl and ferric chloride used in this determination were reagent grade
or better and were obtained through standard chemical supply houses.
Material used in the deproteinization of calf thymus DNA.

Sodium

lauryl sulfate used was a product of Sargent-Welch Co., Skokie, Ill.
and was used as received.

Absolute ethanol used in this procedure

and throughout this work was Rossville Gold Shield BranJID, IMC
Chemical Group, Inc . , Agnew, Ca.
Material used in the determination of inorganic phosphate.

Inor-

ganic phosphate, used as an alternative method for determining nucleic
acid concentration, was quantitated by the method of Fiske and Subbarow (120).

The chromogenic reagent, 1-amino-4-naphthol sulfonic

acid, was purchased from Eastman Organic Chemicals, Rochester, N. Y.
Before use the reagent was recrystallized (120).

Sulfuric acid,

sodium sulfite and sodium bisulfite were reagent grade.

Reagent

grade monobasic potassium phosphate used as a phosphate standard was
heated overnight at 110° before weighing and prepared as described
by Fiske (120).
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Methods
Animal care and housing
Upon arrival, the rats were held six to a cage in stainless
steel cages with wire mesh bottoms.

Feeding during this period was ad

libidum with pelleted commercial laboratory diet and water.

The mice

were held ten per cage in standard polycarbonate rat cages with
synthetic bedding throughout the acclimation and experimental periods.
Feed was the same as that for the rats and was provided ad libidum.
Temperature in the animal .facility was kept at a constant 72° with a
12 hour photoperiod.
At the start of the "induction period" ground commercial laboratory diet adulterated with inducer (100 ppm) was substituted for the
pelleted food.

The treated feed and water were given ad libidum.

Control animals received ground laboratory diet that contained no
chlordane.

The duration of the induction period was 10 days.

During

this time the feces trays (rat cages) or bedding (mouse cages) were
cleaned and fresh water was provided daily.

Food was replenished as

needed.
Feed preparation
Pelleted commercial laboratory diet was ground in a burr mill to
the consistency of coarse sand.

Unlabelled pure cis-chlordane, trans-

chlordane, phenobarbital or a mixture of 75% cis-chlordane and 25%
trans-chlordane was weighed out in a quantity sufficient to yield 100
ppm by weight.

The chlordane was dissolved in 50-100 ml of diethyl

ether and added to the ground feed.

This mixture was agitated in a

commercial mixer until the odor of ether was no longer detectable;
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usually one half hour.

Feed for contro l animals (uninduced) was made

up by the same procedure omitting only the inducer compound.

The

mixer blade and bowl were washed in detergent and rinsed with acetone
and hexane between batches to prevent the carry-over of chlordane i nto
control feed.
The inducing feed was formulated so that the inducer compound
corresponded exactly to the intended 14 C-l abelled microsomal substrate
with th e exception of the feed containing phenobarbital.

Feed for

three animal s for 10 days consisted of 1.0 to 1.5 kg in the case of
the rats and 0.5 to 0.75 kg for 10 mice.

Feed was stored at room

temperature in hexane washed polyethylene containers with push on tops.
Sacrifice of the animals and excision of
the livers
Rats.

At the end of the 10 day induction period, feed was re-

moved from the induced and control animals for 24 hours.

The rats

were killed wit h ether and the liver s quickly removed and blotted on
wet paper toweling to remove excess blood.

The hilus was dissected

out and the bulk of the liver was weighed, minced with scissors into
an ice cold homogenizer jar and homogenized in cold 1.15% KCl at 4°C
in a ratio of 1 g of liver to 4 ml of KCl solution.

Homogenization

was in a Lourdes homogenizer operated at 70% maximum speed for 1.5
minutes in an ice bath.

Prior to further processing, like homogenates

were pooled and packed in ice .

Three induced rats and three control

rats provided more than enough liver homogenate for an experimental
run.

Mice.

The mice, like the rats, were killed with ether.

The

liv ers were excised and the gall bladder, removed with the liver i n

67
this case , was carefully dissected away.

The lobes of the livers

were cut away from the hilus, weighed, pooled according to pretreatment and homogenized.
th is procedure.

Ice temper atures were maintained throughout

Ten mouse livers yielded between 36 and 50 ml of

homogenate depending on the pretreatment.
Preparation of microsomes
Rats.

Rat microsomes were prepared from the respective pooled

li ver homogenates basically by the method of Claude (121 ) .

Crude

homogenate was spun in a refrigerated centrifuge at 10,000 x g for
15-20 minutes to sediment large cell fragments including those the
size of mitochondria.

Lipid rising to the top of the tube during

centr ifugation was removed with suction and the supernatant containing microsomes and so lubl e enzymes (hereafter referred to as po stmitochondrial supernatant) wa s decanted, pooled and its volume
recorded.

The measured volumes of the pooled homogenates were used

as guides in the recon st i tution of the microsomes later in the
procedur e.
Post-mitochondrial superna tant was centrifuged for 1 hour a t
85,000 x g in a Beckman Model L preparative ultracentrifuge equipped
with a 40 head to sediment the microsomal fraction.

The supernatant

was discarded and the pellet was resuspended in a convenient volume
of 1.15% KCl using a Potter-Elvehjem homogenizer equipped with a
Teflon pestle.

This suspension wa s resubmitted to ultracentrifugation

under the same conditions as those us ed for the post-mitochondrial
supernatant.

The resultant washed microsomal pellets were suspended

in 1 . 15% KCl and pooled according to origin (control or induced).
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The final volumes were adjusted to equal those of the original postmitochondrial supernatants yielding two microsomal suspensions at
concentrations equivalent, in one case, to 250 mg of induced liver per
milliliter and, in the other case, to 250 mg of contro l l iver per
milliliter.

One mil l iliter of the appropriate suspension was used as

the source of microsomal MFO activity in the final incubation mixtures.

Additional aliquots were removed as needed for the determina-

tion of microsomal protein concentration , aminopyrine demet hylase
activity, HEH activity and the concentration of cyt. P-450.
Mice .

Preparation of ·the mouse liver microsomes directly

paralleled the procedure described for the rat through the initial
ultracentrifugation.

The final ultracentrifugation of the mouse liver

microsomes was carried out in 0.5 M Tris, pH 7.4, that was 0.25 M with
respect to sucrose rather than in the 1.15% KCl that had been used in
the rat procedure.

The purpose for this was to enable the microsomes

to be frozen for use at a later time.

Freezing in Tris-sucrose is a

better method for preserving enzyme activity in stored microsomes
than freezing in KCl (122).
Subsequent to the final ultracentrifugation, the microsomal
pellet was resuspended in the Tris-sucrose buffer at high protein
concentration (> 30 mg/ml) and frozen until needed (approximately 12
days).

The frozen microsomes were thawed at refrigerator temperature

when needed and resuspended with the Potter-Elvehjem homogenizer after
appropriate dilution (122).
was 3 . 0 mg/ml.

Final protein concent ration i n all cases
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In vitro oxidative metabolism of
chlordane

14 c-

An acetone solution (50 micro!) of

14 C-labelled

strate was added to 25 ml incubation flask s.
14 C-cis

pesticide sub-

In the work with the

rich chlordane mixture this corresponded to the addition of

1.54 micromoles of chlordane (labelled plus unlabell ed carrier) having a specific activity of 0.97 mCi per millimole and yielding an
ac tivity of 3.35 x 10 6 dpm per flask.

In the experiments where the

pure chlordane isomers were used the acetone substrate solution added
to each flask also contained 1.54 micromole s of pesticide .

The

final spec i fic activity in the case of tran s-c hlordane was 0.2 mCi
per mi llimole and for the cis-isomer was 0.8 mCi per millimole.

The

activity per flask in the case of the pure tran s -chlordane experiment
wa s 6.8 x 10 5 dpm while that in the pure cis-ch lordane experiment was
2.7 x 106 dpm.

The discrepancy in the specific activities reflect s

the limited amount of labelled pure isomers avai labl e.
Following the addition of the subs trate so lution , the acetone was
driven off wit h N2 and 0.2 ml of et hoxyethanol and a large glass bead
were added to each flask.
flask.

The incubation vo lumes wer e 4.7 ml per

This consisted of 0.5 ml of 0.07 M glucose-6-phosphate in a

0.24 M solution of magnesium sulfate, 0.5 ml of 0.1 M potassium
phosphate buffer at pH 7.4 containing 2 units of glucose-6-phosphate
dehydrogenase and 1.5 ml of phosphate buffer containing NADP, 3.67 mM.
DNA, dis so lved in cold phosphate buffer overnight, was added to each
flask at the rate of 1.0 ml containing 3.0 mg of DNA.

In those

flasks where inhibition of HEH was desired, the contents were made
5 x

1~4M

with respect to TCPO by adding 0.2 ml of a TCPO-ethoxyethan-

70
ol solution, 2.3 mg TCPO per ml, in place of pure ethoxyethanol.
The flasks, so charged, were placed in a metabolic shaki ng incubator at 37° with 0 2 gassing for 5 minutes.

At the end of this

period the incubation was started by adding 1 .0 ml of the appropriate
microsomal preparation to each flask.

The incubation time in all

cases was 30 minutes.
The procedure was altered somewhat in t he control groups where
the reduced NADP generating system was omitted from the flasks to inactivate cyt. P-450 and prevent oxidative metabolism.
no NADP, G-6-P or G-6-PDH were added.

In this case

Instead, volumes of buffer and

magnesium sulfate solution corresponding to the volumes carrying these
components were added in their place.
the same.

All other additions remained

TCPO, of course, was not added to the control flasks.

Treatment of the post-incubation microsomal
supernatant and the isolation of DNA
Separation of the soluble DNA form the RNA and protein contained
in the microsomes was carried out according to th e method of Speier
and Wattenberg (123) with slight modifications .
stopped by cooling the flasks in an ice bath.

Incubations were
While maintaining the

ice temperature, the contents of each flask were added to an ultracentrifuge tube and diluted to volume with 0.1 M phosphate buffer,
pH 7.4.
hour.

This was followed by ultracentrifugation at 85,000 x g for
The use of 1.15% KCl as a diluant at this stage was strictly

avoided because it caused considerable precipitation of the DNA.
Following centrifugation, the supernatant containing the DNA was
decanted from the microsomal pellet into 50 ml glass stoppered
centrifuge tubes.

The contents of each tube were made 0.57 M with
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respect to NaCl and 2 volumes (rough l y 25 ml) of cold absolute
ethanol were added.

The tubes were capped and inverted several times

causing the DNA to form a stringy, gelatinous precipitate.

The

precipitate was removed by winding it around the tip of a Pasteur
pipe tte and transferred to another SO ml tube containing an additional
10 ml of cold absolute ethanol.

The DNA was allowed to soak overnight

at refrigerator temperature.
On the following day the DNA precipitates were spun down and the
ethanol pooled with the microsoma l supernatant and ethanol mixture
fro m which it was originally precipitated.

These aqueous ethanol

fractions (a separate fraction for each incubate) were refrigerated
for later extraction .

Th e precipitated DNA was dissolved in 5 mM

citrate buffer a t pH 7.4 (123).
The recovered DNA wa s deproteinized as described by Sevag (124).
The tubes containing the DNA were shaken vigorously in the presence
of chloroform: i soamyl a l coho l (24:1, v:v) for 30 minutes and centrifuged to break up any resulting emulsion.

The aqueous phase was

pipe tt ed away without disturbing the chloroform-protein emulsion at
the interface.

This procedure was used twice or until no emulsion

formed at the interface.

The DNA containing aqueous phase was

recovered and the chloroform was discarded.
Each aqueous , deproteinized DNA sample was extracted with diethyl
ether until scinti llation counting of the extracts showed a constant
level of radioactivity.

The DNA was then precipitated as outlined

above, wa shed with ethanol and acetone and dried.
Th e dried DNA samples were dissolved in 1.0 ml of distilled
water and hydrolysed by adding an equal volume of 1.0 N perchloric
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acid and heating in a 70° water bath for lS minutes (12S).

Tests of

DNA concentration were performed on appropriate aliquots of this
solution.

One milliliter aliquots of these solutions were added to

scinti llation vials and counted .
Treatment of recovered microsomes
Microsomal pellets recovered from the ultracentrifugation of the
incubation flask contents were loosened from the bottom of the tubes
and rinsed into lS ml conical tubes with 2 ml of standard saline
citrate (126).

Bovine pancreatic ribonuclease (1% in O.lS M NaCl,

pH S) was added to each tube to give a final concentration of SO
micrograms per ml.

Each tube was covered with a marble to prevent

evaporation and incubated overnight at 37°.
At the end of the incubation period an equal volume of O.S N
perchloric acid was added to each tube.

The contents were mixed,

allowed to sit for S minutes and spun down.

The enzymatically

hydrolysed RNA remained in the super natant and the perchloric acidinsoluble protein formed a pellet on the bottom of the tube.

The

supernatant was immediately decanted into SO ml glass-stoppered
centrifuge tubes.

The protein was washed with 2 ml of O.S N per-

chloric acid and recentrifuged.

The wash was added to the perchloric

acid fraction containing the hydrolysed RNA.
The RNA fractions were extracted with aliquots of diethyl ether
to remove non-covalently bound 14 C-labelled chlordane and its metabolites.

Extraction was repeated until a constant level of radio-

activity appeared.

Routinely, 20 to 30 extraction cycles had to be

performed before constant radioactivity was attained.
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Residual ether was removed from the RNA fractions with a stream
of N2 and they were split for the determination of RNA content and
bound radioactivity.

RNA ribose was measured by the orcinal method

(125).

The perchloric acid-insoluble pellet was made up of denatured
microsomal protein.
extraction.

Residual chlordane was removed by exhaustive

The protein, with unbound radioactivity removed, was

solubilized by treatment with 1.0 N NaOH (127).

Fifty microliters of

this was then assayed for protein concentration in the presence of
NaOH as described by Lowry, et al. (127).
solubilized bovine serum albumin.

The standard used was NaOH

The remainder was assayed for

bound radioactivity by scintillation counting.
Scintillation counting of RNA, DNA and protein
recovered from microsomal incubations
Scintillation counting was performed on a Packard Tricarb scintillation spectrometer.

Quench correction was by the channels ratio

method after calibration with chloroform quenched samples containing
0.1 ml 14 c-toluene (4.31 x 105 dpm) in a toluene based cocktail.

To

increase the accuracy of these quenched standards, 1.0 ml of 0.5 N
perchloric acid was added and neutralized with 1.0 N NaOH prior to
the addition of the scintillation cocktail and the 14 c-toluene.
DNA and RNA samples containing perchloric acid were prepared for
counting by adding the appropriate aliquot to the scintillation vial,
neutralizing the acid with 1 .0 N NaOH (to pH paper) in the vial and
then adding 14 ml of a toluene based cocktail.

The cocktail consist-

ed of 5.0 g PPO, 0.5 g dimethyl POPOP, 333 ml of Triton X-100 and
tolu ene to make 1 liter (128).

Protein solubilized with 1.0 N NaOH
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was prepared for counting by the same method but neutralizati on was
with glacial acetic acid rather than base.

The samples were counted

three times for 30 minutes.
Enzyme assay procedures
Evaluation of the metabolic activity of the microsomal preparations used in the binding studies was required to make the results
meaningful .

Two specific assays of enzymatic activity and cyt . P-450

analysis were performed on control and induced microsomes.
Cytochrome P-450 was determined as outlined by Omura and Sato
(72).

This method allows the cyt. P-450 to be determined in the

presence of other cytochromes by taking advantage of the characteristic absorbance at 450 nm when it is binding carbon monoxide while in
the reduced state.

The results are reported as the change in optical

density at 450 nm upon binding carbon monoxide per milligram of
microsomal protein.

Microsomal protein was measured by the method of

Lowry, et al. (127).
The activity of the microsomal MFO's was evaluated as the ability
to demethylate aminopyrine as described by Mazel (129).

The

procedur~

designed for use with post-mitochondrial supernatant, was modified for
use with microsomes by the inclusion of glucose-6-phosphate dehydrogenase (2 units per incubate) in the incubation mixture.

Activity,

in this case, is reported as moles of formaldehyde produced per milligram of microsomal protein .
Microsomal HEH activity was determined by the method of Oesch, et
al. (93).

This method utilizes the fact that 3H-styrene oxide is con-

verted to the more water soluble 3H-styrene dihydrodiol by HEH.

The
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dihydrodiol is extracted almost exclusively into ethyl acetate after
removal of unreacted styrene oxide with petroleum ether.

Results are

expressed as moles of styrene dihydrodiol formed per milligram of
microsomal protein.
Statistical analysis
Results were analysed by analysis of variance using a factorial
design as described by Winer (130).

Significance was tested using an

F-test after partitioning the treatment sum of squares according to
planned comparisons.

Significance was assumed when P equalled 0.05 or

less.
In the case of the rat data several samp les were lost or otherwise altered so that their usefulness was destroyed.

This resulted in

treatment groups of unequal sizes and made data analysis by the
classical analysis of variance technique impossible.

In th is case,

the data were analysed by the method of unweighted means (130) in
which unequal group sizes are compensated for by the use of the
harmonic mean instead of the actual group mean.

Indications to this

effect are given in the tables where this applies.
In the mouse data, where very few samples were lost, a missing
value was compensated for by the use of the group mean instead of the
missing value.

In these cases a degree of freedom was sacrificed in

the calculation of the error mean square to compensate.
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RESULTS
The planning and execution of this work were guided by one factor
more than any other.

A comparison of the binding behavior of the

chlordane isomers had to be made to tie this work to previous investigations in which the metabolism of cis- and trans-chlordane had been
compared and found to be different.

A comparative study, of course,

necessitated the use of radioactively labelled pure chlordane isomers.
And while these were on hand, the quantities were sufficient for only
one major experiment.
Fortunately, a considerable quantity of a radioactively labelled
cis-chlordane rich mixture of the pure isomers was also on hand.

This

wa s a gift of the Velsicol Chemical Corp . and consisted of 25% transchlordane and 75% cis-chlordane.

The decision was made to proceed

with the inve s tigation using this mixture in preliminary trials and
methods development work and the small quantity of the labelled pure
isomers for a final experiment.

For this reason the experiments in

which rats were used were carried out with the labelled cis-chlordane
rich mixture as substrate.

The labelled pure isomers were used only

in the experiment in which the mouse was the experimental species.
Enzyme, Substrate and Induction Effects on
Covalent Binding of 14 C-Chlordane to
Protein, RNA and DNA in the Rat
and Mouse in vitro
The rat
The experiments under discussion here were of factorial design.
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This allowed the simultaneous evaluation of the effects of a variety
of biochemical manipulations.

The results of the experiment in which

rat liver microsomes were used are presented in table l in such a way
that comparison of the group means for a given treatment is possible.
The effects of chlordane induction and the inhibition of MFO and HEH on
the binding of chlordane to protein, RNA and DNA were investigated.
Factorial analpis of the rat liver binding results.

The analysis

of variance for the rat experiment is shown in table 6 (Appendix).

As

is evident from the table, the only statistically significant effect
in this case was induction and this occurred only in the protein group.
The slight significance appearing in the interaction mean square for
protein arose as the result of the strong effect of pretreatment carried over into the interaction mean square.
Enzyme effects.

This category included the effect of MFO's and

the effect of HEH inhibition on binding.

Deficiencies in the design

of the experiment made it necessary to combine all of the enzymatic
manipulations into a single category called enzyme effects. 1
No significance was found to be attached to the enzyme effects
category in the analysis of variance for any of the macromolecules.
However, removal of the enzymatic effects from the influence of pretreatment by the use of the t-te s t on means within the two pretreatment groups enabled some significance to surface. 2

In the induced

group, MFO inhibition exerted a slight but significant protective
effec t (95% level) against chlordane binding to protein .3
lsee footnote c, Appendix table 6.
2 See

Appendix table 7A, comparisons 2 and 3.

3see Appendix table 7A, comparison 2, protein column.

In the

Table 1.

Summary of the effects of pretreatment and hepatic micro somal enzyme activity on the covalent
interaction of 14 C-chlordane with micro somal protein and RNA, and calf thymus DNA during
metabolism by rat liver in vitro.a
Microsomal enzyme activityb

MFO

Substrate
A.

HEH

Chlordane

None

(nmoles chlordane bound/mg. protein)d

Interaction with protein.
+

Pretreatmentc

+

7.542

i

0.485

5.061

8.906

i

0.817

5.503

8.572

i

1.221

3.726

i

0.692

i

0.212

25% trans- 75%

cis-chlordane

+

mixture .

B.

(nmoles chlordane bound/mg. RNA)e

Interaction with RNA.
+

+

1.151

i

0. 042

0.908

1. 001

i

0 . 139

1.032

l. 052

i

0.063

0.895

i

0.039

i

0. 041

25% trans- 75%

cis-chlordane

+

mixture.
+

Table l.

Continued

Microsomal enzyme activityb
Sub strate
C.

MFO

HEH

Interaction with DNA.

25% trans- 75%
cis-chlordane
mixture.

Pretreatmentc
None

Chlordane

(nmoles chlordane bound/mg. DNA-P)f

+

0.086 • 0.043

0.064

+

0 . 083 • 0.011

0.068

0 . 068 ' 0.030

0.066 • 0.003

+

±

0.005

aincubation conditions: to a 25 ml flask were added in order; 1 . 54 micromoles of a mixture of chlordane
isomers (75% cis:25% trans) with a specific activity of 0.97 mC/mmole, 0.2 ml of ethoxye thanol, 0.5 ml
of a 0.25 M solution of MgS0 4 ·7 H20 0.07 M with respect to glucose-6-phosphate, 0.5 ml 0.1 M potassium
phosphate buffer pH 7.4 containing 2 units of glucose-6-phosphate dehydrogenase, 1.5 ml phosphate buffer
3.67 mM with respect to NADP and 3 mg DNA dissolved in 1.0 ml phosphate buffer . In those flasks where
inhibition of hepat ic epoxide hydratase was desired, the contents were made 0.5 mM with respect to TCPO.
Inhibition of mixed-function oxidases was by omission of NADP, G-6-P and G-6-PDH from the incubation
mixture. Final volume was 4.7 ml. Incubation was for 30 min with 0 2 gassing and was begun by the
addition of the microsomes.
bMFO = mixed-function oxidases. HEH = hepatic epoxide hydratase. Enzyme inhibition is indicated by a
( - ). Details of the inhibi tions are given in note a.
cPretreatment was with a mixture of cis and trans chlordane (3 to l by weight) at 100 ppm in feed for 10
d~ys.
Unpretreated animals were given unadulterated feed.
1.5 mg microsomal protein added per incubate. Values given are the means • the S. E. for 5 samples.
(Values with no S. E. are derived from only l sample as the re sult of a laboratory accident.)

Table l .

Continued .
Microsomal enzyme activityb

Substrate

MFO

HEH

Pretreatment
None

c

Chlordane

~.56 mgmicrosomal RNA added per incubate as determined by average post incubation recovery.
Nalues with no S . E. are derived from only 1 sample a s the result of a laboratory accident.)
f3. 0 mg "buffered" calf thymus DNA added per incubate.
Nalues with no S. E. are derived from only l sample as the result of a laboratory accident.)

00
0
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unpretreated group, HEH inhibition produced a slight but significant
protection against binding to RNA (95% level). 1 Only these two of the
twelve comparisons made showed significance.

There was no significance

attached to any of the t-tests comparing the effect of enzyme inhibition versus no inhibition on chlordane-DNA interaction when pretreatment was held constant.

The indication was that inhibition of the

enzymes studied had no effect on the covalent binding of chlordane
derived material to DNA in the in vitro rat liver system. 2
Pretreatment.

Table 78 (Appendix) presents a more detailed eval-

uation of the effect of pretreatment than that shown in the analysis
of variance.

t-Tests comparing the group means representing no inhibi-

tion allowed only the effect of pretreatment to show.

The results

show that chlordane pretreatment significantly reduced chlordane binding (99% level) to protein and RNA but had no effect on binding to
DNA. 3
The mouse
The mouse was used in the final experiment of this investigation
to which the labelled pure isomers were commi tted. Table 2 gives the
results of this experiment.
The investigation of pretreatment effects was expanded in the
mouse work due to the fact that pure isomers were used as substrate
instead of the mixture used with the rat.

This necesssitated the use

of two different chlordane pretreatments; one with each isomer.
!Appendix table 7A, comparison 3, RNA column.
2Append ix table 7A, comparisons 1-4, DNA column.
3Appendix table 78, comparison 5.

Table 2.

Summary of the effects of pretreatment, substrate and hepatic microsomal enzyme activity on the
covalent interaction of 14 C-chlordane isomers with microsomal protein and RNA, and calf thymus
DNA during metabolism by mouse liver in vitro.a
Microsomal egzyme
act1v1ty

Substrate
A.

MFO

HEH

Chlordane

Interaction with protein.

Cis
Trans

+
+

Cis
Trans

+
+

Cis
Tr a ns

+
+

+
+

B.

Pretreatmentc
None

(nmoles chlordane bound/mg protein)d
1. 710 • 0.142
1. 743 • 0.138

3 . 599
2.304.

1.120
0.161

3.976 • 0.165
2 . 131 i 0.130

2.494
2.337

0.283
0.110

1. 741 • 0.403
2.365 i 0.161

3.236 i 0.280
2.258 • 0.168

0.244
0.047

2.468
1.853

2.916
2.181

3.000
1.878

i
i

i
i

Interaction with RNA. e

Cis
Trans

+
+

Cis
Trans

+
+

+
+

Phenobarbital

i
i

i
i

0.210
0.178

i
i

0.212
0.212

(nmoles chlordane bound/mg RNA)d
0.339 i 0.076
0.068 • 0.038

0.305
0.061

0.350
0.013

0 . 262
0.121

i
i

0.081
0.013

i
i

i
i

0.073
0.036

0.261 • 0.071
0 . 031 i 0.031

0.080
0.021

0.371
0.112

i
i

0.046
0.037

00
N

Table 2.

Continued
Microsomal e~zyme
act1v1ty

Substrate

MFO

Cis
Trans

+

c.
Cis
Trans
Cis
Trans

Cis
Trans

HEH

Pretreatmentc
None
0 . 291
0.006

Chlordane
±

±

0.084
0.006

Interaction with DNA.f
+

+
+

+

±
±

0.020
0.016

0.210
0.073

±

±

0 . 006
0.047

0.033
0.000

±

0.007

(nmoles chlordane bound/mg DNA-P)d
0.017
0.000

±

0.010

0.000
0.000

+
+

0.147
0.031

Phenobarbital

0. 040
0.000

0.033
0.000

±

0.012

0.000
0.000
0.014

0.059
0 . 000

0.004

0.004
0.000
±

0.003

0.031
0.000

±

0.007

aincubation conditions: As in note a Table 1 but mouse liver microsomes added at the rate of 3 mg of
microsomal protein per incubate. Substrates in this case were the pure isomers rather than the cis-trans
mixture used in the rat work. Chlordane concentration was 1.54 micromoles/flask with specific activities
of 0.2 mC/mM (trans) and 0.8 mC/mM (cis).
bMFO = mixed-function oxidase. HEH = hepatic epoxide hydratase. Enzyme inhibition is indicated by a
minus (-). Details of inhibition are given in note a Table 1.
CPretreatment was with the indicated material at 100 ppm for 10 days in feed. In the case of chlordane
pretreatment, the inducer corresponds to the isomer used as substrate.

Table 2.

Continued
Microsomal enzyme
activityb

Subs t rate

~1FO

HEH

Pretreatmentc
None

Chlordane

dValues given are the mean
S. E. for 3 observations.
e0.35 mg microsomal RNA added per incubate determined by average post incubation recovery.
f3.0 mg calf thymus DNA per incubate. See note f Table l.

Phenobarbital
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Phenobarbital pretreatment was added to the design in an attempt to
stimulate binding in analogy to the halogenated methanes.

Other

factors under investigation were the effect of substrate, MFO inhibition and HEH inhibition.

The dependent variables observed included

binding to microsomal protein, microsomal RNA and added calf thymus
DNA, as in the work with rat liver described above.
Factorial analysis of mouse liver mediated binding.

The analysis

of variance table generated from the data produced in the mouse experiment is given in Appendix table 8.

Again, the effects of enzyme inhi-

bition had to be combined under a single heading:

enzyme effects.

This category showed no significance in the analysis of protein binding
re su lts mainly due to the great variability within the group.

The sig-

nifi cance arising in the RNA column (95% level) was difficult to explain.

The RNA group means themselves (table 2) certainly did not in-

dicate any pattern and testing of the individual group means showed no
significant differences for either MFO or HEH inhibition when all of
the other variables were held constant. 1 Perhaps the slight signifi cance indicated for enzyme effects on binding to RNA is an indication
of the sensitivity of the analysis of variance technique over thet-test .
Enzyme effects also showed no significance in the DNA binding
data when the effect of MFO inhibition on groups in which cis-chlordane was th e substrate were analyzed.

Inhibition of HEH reduced the

binding of cis-chlordane to DNA to zero (table 2). For this rea son,
the effect of HEH on cis-chlordane binding to DNA could not be evaluated s tatistically. 2 The effect, however, is clear.
1Appendix table 9A and 98, comparisons 1-12.
2Appendix table 98, DNA column.

The cis-
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chlordane derived material arising during microsomal metabolism in
mouse liver preparations is activated by a HEH mediated process.
As is evident from the analysis of variance (Appendix table 8) the
effect of pretreatment was strong in the case of protein and DNA.

Sub-

strate was highly significant in protein and RNA as shown by its main
effect mean square in table 8.

The effect of substrate on binding to

DNA could not be evaluated, as with HEH inhibition, due to the values
of zero for trans-chlordane binding.

But the nature of the data again

forces one to conclude that it was very significant.
The interactions of the main effects in the mouse data bear closer
scrutiny.

The mean square for substrate-pretreatment interaction in

the analysis of variance table (Appendix table 8) in protein does not
show significance in spite of the fact that the main effect of each of
these was very significant in its own right.

The indication is, then,

that whatever effects the enzymatic manipulations (enzyme effects) had
on binding were the same for both substrates.

Looking back at the mean

s quare for enzyme effects, it becomes evident that this is true.
Enzyme inhibition had no effect on any of the pretreatment groups.

The

significance of the substrate-enzyme effects interaction and pretreatment - enzyme effects interaction in the protein data simply reflect
the significance of pretreatment in the former and substrate in the
latter interactions.

The nucleic acid groups showed no significant

interaction effects.
Enzyme effects.

As was true with the rat data, this treatment

category was a composite of the effect of both MFO and HEH inhibition
because of a failure to include an experimental group in which both
enzymes were inhibited.

This deficiency destroyed the balanced
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factorial design of the experiment and made it impossible to isolate a
main effect of MFO and a main effect of HEH during the partitioning of
the treatment sum of squares.

Table 9 (Appendix) gives a detailed

analysis of the effect of MFO inhibition on 14 C-chlordane binding based
on t-tests within treatment groups.

Two of the protein treatment

groups showed significant effects due to MFO inhibition. 1

Both of

these lie in that portion of the experiment in which cis-chlordane was
used as substrate.

The statistical analysis showed that in uninduced

microsomes, inhibition of MFO activity substantially increased binding
by cis-chlordane to mouse liver microsomal protein.
Cis-chlordane binding to microsomal protein was also significant
when phenobarbital was the inducer.

In this case, MFO inactivation

had a protective effect on the protein much the same as one would
expect if the microsomal MFO's were performing an activation on chlordane.2

Analysis of the nucleic acid binding data yielded no indication

of any significant effect on binding due to MFO inhibition. 3
Some of the most interesting results arising in this investigation
were those that resulted from the effect of HEH inhibition on binding
to macromolecules in the mouse liver microsomal system. 4

In the

protein group only the non-induced microsomes mediated any increase in
binding when the HEH inhibitor was added.

Binding to protein by

material derived from both isomeric substrates was increased under
!Appendix table 9A, comparisons

and 3, protein column.

2Appendix table 9A, comparison 3.
3Appendix table 9.
4Appendix table 98, comparisons 7 through 12.
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the se conditions.

For some reason the induced groups showed little or

no effect on binding to protein due to the inactivation of HEH. 1 This
wa s true under the influence of both substrates and for microsomes
from mice pretreated with cis-chlordane, trans-chlordane or phenobarbital.
HEH inhibition had no apparent effect on binding to RNA.
DNA, however, the results were striking.

With

With cis-chlordane as sub-

strate, inhibition of HEH reduced binding to unmeasurable levels.

In

one of the three pretreatment groups, phenobarbital, there was slight
binding in the presence of HEH inhibition but it was significantly
lower (95% level) than binding in the presence of active enzyme. 2 The
indication is that HEH somehow contributes to the activation of cischlordane to a form which binds to DNA.

No fo rmal statistical compari-

sons were possible with the trans-chlordane group because tran s-ch lordane binding to DNA was either unmeasurable or nonexistent under all
of the treatment conditions.
Pretreatment.

The effect of pretreatment on binding is analysed

in Appendix table 9, part C.

No significance was found for binding

to nucleic acids using the t-test.

Unpretreated group means were com-

pared with pretreated group means within the RNA and DNA data.3
Simi lar comparisons showed significance when the means of the results
of chlordane binding to protein were evaluated.

The binding of cis-

chlordane derived material to protein was more than tripled by
IAppendix table 9B, comparisons 8, 9, 11 and 12.
2Appendix table 9B, comparison 9, DNA column.
3Appendix table 9C, comparisons 13 through 16, RNA and DNA
columns.
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phenobarbital pretreatment. 1 Likewise, trans-chlordane binding to
protein was increased by pretreatment with trans-chlordane 1 .

Effects

such as these are what would be expected if binding to protein was
dependent on the MFO activation of chlordane.

But the experimental

significance of a difference due to chlordane pretreatment on the one
hand and phenobarbital pretreatment on the other is a bit elusive.

It

may be important to note in this context that in the case of binding
to protein as it is effected by pretreatment, the tests of cis-chlordane pretreated microsomes acting on cis-chlordane versus non-pretreated microsomes and the test of phenobarbital pretreated microsomes
acting on trans-chlordane versus non-pretreated microsomes fell just
short of significance at the 95% level. 2 The indication is that the
isolation of the two significant effects in the protein results may
only be the result of variability and small group size.

It is

probable that under better experimental conditions and with larger
groups pretreatment would have been significant in all of the protein
groups.

The nucleic acids, on the other hand, showed no tendency to-

ward significance due to pretreatment effects.3
Substrate.

The results of the analysis of variance of the mouse

experiment indicate that the effect of substrate was the most significant factor tested (Appendix table 8).

Differences in the concentra-

tion of bound material arising from the two labelled chlordane
isomers were significant at the 99% level by F-test in the protein
1See table 2, part A and Appendix table 9C, comparisons 14 and
15, protein column.
2Appendix table 9c, comparisons 13 and 16.
3Appendix table 9C.
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and RNA data.

A stark difference appeared between cis- and trans-

chlordane binding to DNA.
chlordane did.

Trans-chlordane did not interact while cis-

It is because of this that no substrate effect analysis

was run on the DNA binding data in the analy sis of variance.

1

The dif -

ference was maintained regardless of pretreatment or manipulation of the
microsomal enzymes.

This strong effect of substrate required a closer

look isolated from the other variables. Again, this was carried out
using the t-test. 2
The chlordane-protein covalent interaction was examined in this
manner.

In spite of the strong significance of substrate in the over-

all analysis of variance, the magnitude of the binding to protein found
when cis- and trans-isomers were compared was different in only 2/3 of
the treatment groups. 3 For example, in the groups where there was no
enzyme inhibition 4 or where HEH was inhibited, 5 only the phenobarbital
pretreated microsomes mediated a significant difference with less
binding by trans-chlordane derived material than by that from cischlordane.

In microsomes where MFO had been inactivated the pattern

was reversed.G

In this case phenobarbital pretreatment caused no dif-

ference in the concentration of bound material between the two isomers
while in chlordane pretreated and non-pretreated microsomes there was
1
See Appendix table 8, footnote c.
2
Appendix table 9D, comparisons 17 through 25.
3Appendix table 9D, protein column.
4 Appendix

table 9D, comparisons 17' 18 and 19, protein column.

5Appendix table 9D, comparisons 20, 21 and 22, protein column.
6Appendix table 9D, comparisons 23, 24 and 25, protein column.
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less binding by material derived from trans-chlordane.
In contrast to protein, RNA bound radioactivity differed significantly with substrate in nearly every treatment group. 1 This seems to
carry over into the DNA results as well.

The indication is that a dif-

ferent mechanism is at work in the processing of chlordane for binding
to nucleic acids than that involved in processing prior to protein
binding.

In the results of binding to RNA every significant difference

due to substrate involved greater binding by cis-chlordane than by
trans-chlordane. 2 The only instance where there was no significant
difference between the means in the RNA results was in the chlordane
pretreated, HEH inhibited groups.3
The Effect of Induction and Other Factors on the
Activity of Microsomal Constituent Enzymes
Characterization of the effect of induction
on mouse and rat liver microsomes
Experimental microsomes were assayed for the effect of pretreatmenton MFO activity (as aminopyrine demethylase), HEH activity and the
level of cyt. P-450.

A summary of the results for both rat and mouse

liver microsomes is given in table 3.

In the case of the rat, pre-

treatment for 10 days with a mixture of 25% trans-chlordane--75% cischlordane at 100 ppm in feed caused an increase in all three of the
microsomal parameters measured.

A similar general increase in

activity was seen in the mouse although different pretreatments were
!Appendix table 90, comparisons 17 through 25, RNA column.
2See table 2, part B.
3Appendix table 90, comparison 21, RNA column.
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Table 3.

The effect of pretreatment on microsomal enzymatic activity
expressed as percent of control.a

Speciesb

Pretreatmentc

Mouse

Rat

Aminopyrine
demethylased

Cytochrome Hepatic epoxide
P-450e
hydratasef

Phenobarbital

141

137

276

Cis-chlordane

204

156

338

Trans-chlordane

178

171

456

25% trans-chlordane
75% cis-chlordane
mixture

128

228

144

aNon-pretreated control = 100%. Because of the manner in which the
data were collected, they did not lend themselves to statistical
etaluation.
Male Sprague-Dawley rats and male C57 black/6J Fl hybred mice.
cPretreatment was with 100 ppm of the appropriate compound in feed
fgr ten days.
Calculated as mg Ch 20 formed per mg microsomal protein.
~Calculated as millimoles P-450 per mg microsomal protein.
Calculated as micromoles styrene dihydrodiol formed per mg microsomal protein.
used.

In comparing the responses of the rat and the mouse to pre-

treatment it is evident from table 3 that the profiles differ.

The

order of increasing activity in induced rat liver microsomes can be
expressed as:

MFO

<

HEH

<

cyt. P-450.

microsomes roughly show the order:

By contrast, the mouse liver

Cyt. P-450 < MFO < HEH.

These

differences are probably partially responsible for the differences
seen in binding behavior between the two species.
The differences between the pretreatment groups in the mouse data
is also of interest.

The chlordanes seem to be more potent inducers

of the parameters tested than the barbiturate.

This is especially

interesting in the case of epoxide hydratase which is known to respond
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very subs tantiall y to induction by phenobarbital.
The enhancement of epoxide hydratase activity by pretreatment
with the chlordane mixture was investigated in some detail during the
early phase of this work.

Figure 9 shows the enhancement effect

graphically at one level of microsomal protein.

Clearly, pretreatment

with chlordane increases the concentration of total epoxide hydrolysed
in the standard assay for HEH activity.

Unfortunately, this was not

repeated with mouse liver or to evaluate the effect of pretreatment
with pure chlordane isomers .
The effect of oxychlordane on rat liver
microsomal HEH activity
Oxychlordane was added to HEH assay mixtures at three concentrations to test the possibility that it was an inhibitor of the enzyme.
The results of this experiment are given in table 4 .
Table 4.

The effect of added oxychlordane on the activity of hepatic
epoxide hydratase in rat liver microsomes.a

Oxychlordane
concentration

Micromoles of styrene diol
mg microsomal proteinD

t-valuec

% of control

5 X 10- 3 M

0.318 • 0.126
0.358 • 0.018
0.328 ' 0.020

0.3961
7.6504**
3.0964*

108
122

None

0.239 • 0.010

5 X 10- 5 M
5 X 10- 4 M

112

100

aStandard epoxide hydratase assay using uninduced male Sprague-Dawley
rats. Pooled microsomes from two rat s were used. Epoxide hydratase
substrate concentration 0.8 micromoles tritiated styrene oxide per
agsay.
0 . 2 mg microsomal protein were added to each incubate . Values given
are th e mean • standard deviation of three observations.
cDetermination of "t" with 5 degrees of freedom.
*Indicates significance at the 95% level. **Indicates significance
at the 99% level.
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As is evident from the results, the presence of oxychlordane did
not have an inhibitory effect on the enzyme.

At the two higher concen-

trations a slight but significant enhancing effect was evident.

This

data, of course, is only indicative of what happens in the presence of
styrene oxide the HEH substrate in the assay system.

No attempt was

made to generalize these results to other substrates of HEH.
The Comparison of Relative Binding to Protein, RNA
and DNA in Rat and Mouse Liver Systems
Reference to tables 1 and 2 shows that binding to a given macromolecule varied in the order:
both species used.

protein

>

RNA

>

DNA.

This was true for

When the same data are compared for rat and mouse,

generally more chlordane derived material seems to have bound to
protein, RNA and DNA in rat liver microsomes than with those from the
mouse .

The difference in binding profiles must also be considered in the
light of the relative concentrations of the individual macromolecules
available for participation in binding reactions.

Table 5 shows the

amounts of protein, RNA and DNA in an incubation system by macromolecule and species.
It is clear that the difference in protein content between the
rat and mouse liver systems may have had an effect on the concentrat ion of bound material when the results from tables 1 and 2 are compared.

The rat, with only half as much available protein present,

shows a consistantly greater concentration of bound radioactive
material.

The situation is reversed with respect to RNA.

Table 5

shows that a milliliter of rat liver microsomes contained a higher
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Table 5.

Average total amounts of protein, RNA and DNA present in
the in vitro mouse and rat liver microsomal incubate.a

----

Species

Protein

RNA

DNA

Rat
Mouse

1. SO mg
3 . 00 mg

0 .56 mg
0.35 mg

3.00 mg
3.00 mg

aValues given were derived from measurement of microsomal protein content by the Lowry method, measurement of average recovered RNA using
the orcinol reaction and the concentration of the solution of calf
thymus DNA added to each incubation flask. Incubate volume was 4.7 ml.
concentration of RNA than an equal quantity of mouse liver microsomes .
When the experimental results are examined in th1s case, though, the
relationship developed with protein is stil l with us; i.e., a greater
concentration of bound radioactivity is found in RNA after chlordane
metabolism by the rat system than after metabolism by the mouse.
Obviously, the dichotomy between the rat and mouse is not totally a
function of the relative concentrations of the macromolecules under
investigation .
The hypothetical correlation between macromolecule concentration
and the concentration of bound radioactive material breaks down even
further when the DNA results from rat and mouse (tables 1 and 2) are
compared .

In the case of DNA the concentration within all of the

incubates was the same.

Yet the now familiar pattern of rat

>

mouse

for the amount of chlordane derived material bound to DNA persists .
Based on thi s argument, it seems reasonable to conclude that the differences between the rat and mouse are not primarily the result of
the different relative concentrations of the macromolecular species
added to the in vitro system in each case.
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DISCUSSION
Based on the results above it becomes possible to determine
whether the hypotheses formulated as research objectives were correct.
The original purpose of this investigation was to determine if chlordane metabolites bound to cellular macromolecules after processing
by liver and if so was there an isomeric preference in the binding
that correlated to differences that had been seen in the liver microsomal metabolism of the isomers of chlordane.

Questions were also

raised as to whether chlordane binding behavior paralleled that of
other compounds known to exert their toxic effects following a process of metabolic activation and macromolecular binding and whether
in vitro binding behavior in rat and mouse could be correlated with
th e known carcinogenicity of chlordane in the mouse but not in the rat.
Binding to Cellular Macromolecules
It is obvious from the result s that one or both of the isomers of
chlordane interacted with each of the macromolecules in both species
investigated.

Furthermore, the level of binding was sensitive to the

experimental conditions in some cases.

At times, binding was seen to

vary with the state of activity of the microsomal MFO's and HEH,
s pecies, microsomal enzyme induction and substrate isomer.
Isomeric Preference
It was impossible to discern any isomeric preference in the
results from the rat because of the mixture of isomers used as
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substrate .

In the mouse, where the individual isomer s were used, this

route of inquiry was fruitful.

Calf thymus DNA showed a clear prefer-

ence for interaction with the material derived from cis-chlordane in
that binding by trans derived material was so low that it was either
nonexistent or unmeasurable.

Additionally, the data in table 2 show

that when RNA was the target molecule binding by trans-chlordane was
consistantly lower than binding by the cis-isomer.
The study of the interaction of chlordane with mammalian systems
has consistantly shown an isomeric dichotomy.

Cis-chlordane is less

toxic to male rats on an acute basis than trans-chlordane (107) and
cis-chlordane is metabolized to oxychlordane to a lesser extent than
trans-chlordane (106, 107).

There are, as well, indications that

reductive metabolism plays a more prominant role in cis-chlordane
metabolism than in the metabolism of the trans-isomer in the rat (102).
So the fact that differences appear in the covalent interaction of the
chlordanes with nucleic acids is really not surprising.

This phenome-

non probably arises because of the different metabolic patterns attributable to the different isomers.

Confirmation of this, however,

ha s to await a study of the isomers' comparative metabolism in the
mouse.

There is little to be gained by speculation about the identity of
th e molecular species binding to mouse liver nucleic acids at this

point.

The mouse has not been used in any of the existing studies of

the metabolism of chlordane.

Additionally, the reactivity of the

metabolite of interest makes it unlikely that it would be identified
in such a study.

The methods normally used in the study of xenobiotic

metabolism are not designed to dislodge and recover covalently bound
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metabolites for identification.
Concerning the metabolism of chlordane in the mouse and the
iuentity of the activated species, however, two conclusions can be
stated with certainty.

Based on the result of this investigation, one

can safely assume that the mouse, like the rat, metabolizes the isomers of chlordane by different pathways .

Otherwise the differences in

binding seen with the nucleic acids would not have appeared.

Addition-

ally, based on what is known about the production of oxychlordane in
other species and the characteristics of its interaction with epoxide
hydratase shown here, it is safe to say that oxychlordane is not the
material that is covalently interacting with the nucleic acids in this
study.

Information from investigations of the rat and rabbit (102,

103, 106, 107, 109) indicates that if oxychlordane were involved in
the binding, the isomeric preference would have been reversed.

More

oxychlordane evolves from the mammalian metabolism of trans-chlordane
than from cis-.
The isomeric pattern seen with the nucleic acids in the mouse
work breaks down to some extent when one considers binding to microsomal protein.

Comparison of the corresponding values for cis- and

trans-chlordane binding to protein from table 2 shows that the cis-trans pattern seen with the nucleic acids is not evident in the case
of protein.

For example, the amount of bound radioactivity derived

from each of the isomeric substrates was approximately equal when
fully active, unpretreated microsomes were used (Table 2, part A).
This is a reversal of the effect seen with DNA (Table 2, part C).
It is difficult to explain this loss of isomeric preference as
one goes from the nucleic acids to the protein results for the mouse
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liver system.
involved.

It is tempting to say that different metabolites are

One metabolite prefers protein as the target macromolecule

and is produced from both isomers.

The variability of the effec t of

HEH inhibition on the protein binding by this metabolite indicates
that it is something other than an epoxide (Table 2, part A).

The

other metabolite prefers nucleic acid as a binding site, is primarily
a cis-chlordane derivative and behaves, to some extent, as if it
arises from an epoxide precursor dependent on HEH for activation
(Table 2, parts Band C) .
Aside from the question of isomeric preference, perhaps a considerat ion of the preference of chlordane derivatives for a particular
macromolecule is warranted at this point.

The results from both the

rat and the mouse systems indicate that protein is the preferred target molecule.

RNA and then DNA follow based on the relative amounts

of radioactivity bound per unit weight of macromolecule (Tables 1 and
2).

One' s first impression is that this reflects differences in the
total quantities of the macromolecules present in the in vitro system.
In the presence of a constant quantity of activated metabolite the
concentration of the target molecule s would become the limiting factor.
The target molecule present in lowest concentration would exhibit the
highest rate of radioactive decay on a weight basis assuming equal
reactivity toward all three macromolecules on the part of the binding
species and the absence of proximity effects.

If this were true, how -

ever, the amount of radioactive material bound to RNA would have exceeded that bound to both protein and DNA since RNA was present in
the lowest concentration (Table 5).

This was not so in either the rat
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or the mouse.

In both cases the concentration of bound material on

protein and RNA were at least triple the concentration bound to DNA.
Yet the protein> RNA> DNA relationship held.

It was quite c lear that

th is difference is either real or based on some factor other than
target macromolecule concentration.
It is more conceivable that a proximity effect was at work and
contributed to the preference of the active species for the one macromolecule over another.

Protein and RNA, the sites of the greatest

binding, were of microsomal origin and, as such, were in closer
proximity to the activating enzymes than the exogenous calf thymus
DNA.

Assuming such an effect , the difference between the amounts of

chlordane derived material bound to protein and RNA would be a true
reflection of relative reactivity.

The low concentration of material

bound per unit weight of DNA phosphorus, on the other hand, would be
explained by the remoteness of DNA from the site of chlordane ac tivation.

Therefore, no direct comparison can be made, with respect to

reactivity at least, between protein and RNA on the one hand and DNA
on the other.
The fact that DNA i s not a component of microsomes does not make
this effect any less real, however.

The low concentration of DNA at

the site of metabolic activation and the subsequent paucity of binding
may be an artifac t of working in vitro but it also mimic s the actual
situati on within th e cell.

The si te of metabolic activation in vivo

(the endoplasmic reticulum) does not coincide with the highest concentration of DNA.

So the relationship of the DNA to sources of

metabol ic activation in the in vitro sys tem may be a better approximation of reality than was originally apparent.
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Chlordane Binding Behavior Compared to That
of Other Compounds that Bind
After Metabolic Activation
Polycyclic aromatic hydrocarbon carcinogens, halogenated benzenes
and halogenated methane necrogens and chloramphenicol were discussed
above as examples of compounds producing a well characterized toxic
effect whose mode of action is felt to involve covalent binding to
cellular macromolecules.

There are other compounds that fulfill these

criteria, of course, but those above are representative.

Chlordane

behavior, overall, does not fit well with the pattern seen in any of
the groups mentioned.

But there are some illuminating negative cor-

relations.
Cis-ch lordan e binding to DNA
The halobenzenes and halomethane s do not bind to nucleic acids
(49) .

In this sense, then, ch lordane cannot be considered to behave

as these two groups do.

Yet there is a factor in the biochemistry of

carbon tetrachloride activation that was not investigated in this
work with chlordane.

The activation of carbon tetrachloride to its

protein binding free radical(s) is felt to be a reductive process
(50).

The result of recent work with chlordane metabolism suggests

that cis - chlordane is also partially metabolized by reductive
processes (102).

The metabolism of carbon tetrachloride under

reducing conditions leads to increased binding (49) .

If chlordane

metabolism were to be investigated under similar circumstances an
analogy between its activation and that of carbon tetrachloride
might still appear.
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The behavior of chloramphenicol has not been investigated vis-avis nucleic acid binding (60, 61) so no comparison can be made between it and cis-chlordane in this case.

The PAH carcinogens, however,

do interact with DNA and MFO activation and epoxide cleavage are
involved.
Superficially, the comparison of cis-chlordane's interaction with
DNA and that of the PAH carcinogens seemed promising.

In addition to

the production of epoxide activation products by both chlordane and
the PAH's, chlordane and several other cyclodiene insecticides are
reputed to cause cancer irt rodents (7, 115) .

The similarity seems to

fade considerably, though, when one compares the effect of HEH inhibition on the covalent interaction of chlordane and benzpyrene with DNA.
Benzpyrene binding to calf thymus DNA in rat liver microsomal systems
has been reported to increase when epoxide hydratase is inhibited
(41) .

In our system the binding of cis-chlordane was found to de-

crease under those conditions.
Considering the evidence that the active intermediate in benzpyrene binding to DNA is a dial epoxide (38, 44) processed by both
mixed-function oxidases and epoxide hydratase, the effects of epoxide
hydratase inhibition on benzpyrene binding mentioned above seem odd.
One would expect to see a reduction in binding when the hydratase
was inhibited if it participated in activation.

Clearly, more than

one compound must be interacting with DNA as the result of the MFO
activation of benzpyrene.

Some epoxide metabolite must also interact.

Cis-chlordane, on the other hand, behaves as if HEH were indeed an
activator.

When the enzyme is inhibited measurable binding to DNA

drops to zero.
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Cis-chlordane binding to protein
The covalent interaction of cis-chlordane with microsomal protein offers no clear cut analogy to any of the model systems either.
Pretreatment increases binding to some extent (See table 2, part A)
but there is no dramatic increase due to phenobarbital induction like
that seen with the halogenated methanes (50) and the halobenzenes
(49).

Phenobarbital pretreatment was used in the mouse work for the

purpose of investigating this phenomenon.

I hoped that a large in-

crease in binding due to the pretreatment with the barbiturate would
indicate a kindred mechanism at work in both the model compounds and
the chlordanes .

In this sense (binding to protein), therefore, bind-

ing by cis-chlordane differs from that of the model compounds.

Wheth-

er this difference is due to the mechanism of activation or to some
variation in the response of the mouse to phenobarbital induction as
compared to the species used in the CC1 4 work is unknown.

The bromo-

benzene investigations (49, 53, 54) were conducted partially in the
same mouse so the indication, in that case at least, is that the
activation mechanism differs.
The effect of mixed-function oxidase inhibition on cis-chlordane
binding to protein by eliminating the passage of reducing equivalents
to the terminal oxidase (cofactor omission) was interesting.

In the

unpretreated mouse microsomes this inhibition had the effect of
doubling binding of cis-chlordane derived material to microsomal protein.

The effect was highly significant (P < 0.01, Appendix table 9,

comparison 1).

A similar trend was observed with trans-chlordane

binding but in that case the increase in chlordane protein interaction
was not significant.

The magnitude of the binding simply remained
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unchanged from that seen in the fully active microsomes.
One's first impression on being confronted with these results is
to conclude that the inhibition by elimination of the cofactors necessary for th e generation of reducing equivalents was unsucessful.

The

fact cannot be denied, however, that the mixed-function oxidases cannot function either reductively or oxidatively in the absence of
electrons from NADPH.

It may be possible that another microsomal

enzyme is participating in the activation of chlordanes for binding to
protein.

This phenomenon deserves further attention.

Some of the results from the investigation of the binding of
chlordane to protein in the rat (Table l, part A) are germane to this
discussion.

The departure of the rat results from the published work

on CC1 4 and bromobenzene is greater than that seen in the case of the
mouse .

Although phenobarbital pretreatment was not used in the rat

exp eriment s , the effect of chlordane pretreatment was to cause a decrease in the binding in all of the rat experimental groups.

This

indicates , at least for the rat, that the role of mixed-function
oxidase activity is one of inactivation rather than activation of the
binding metabolite.
Trans-chlordane binding to protein
The data on the binding of trans-chlordane derived material to
mouse liver microsomal protein presents a more coherant picture
(Table 2, part A) than the cis-chlordane data.

Pretreatment caused

an increase in binding to protein in fully active microsomes .

Inhi-

bition of hepatic epoxide hydratase caused a general increase in
binding over the corresponding fully active system indicating a
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protective role for this enzyme and the possible participation of an
epoxide.

In this sense the binding of trans-chlordane to protein is

ana logous to what would be expected with bromobenzene (55 ) where an
epoxide is definitely involved in the protein interaction.

However,

in the pretreated, hepatic epoxide hydratase inhibited system the
binding was of the same magnitude as that for the epoxidase inhibited,
non-pretreated liver.

This indicates that the induced increment of

epoxide hydratase had little effect on the binding and leads one to
believe that the increased binding in the fully active enzyme group
wa s due primarily to mixed-function oxidase induction.
Mixed-function oxidase inhibition showed very little effect overall when trans-chlordane was the microsomal substrate.

In this sense

th is work departs from the reports of protein binding from the model
compounds where significant reductions in binding were noticed (50,
54 ).

It may be significant that in tho s e investigations the mixed-

f unct i on oxidases were actively inhibited with, for example, piperonyl
butoxide or SKF 525a.

In this work mixed-function oxidase inhibition

wa s by cofactor omission as was mentioned above.

It is possible

that suffic i ent activity was maintained by the presence of cofactors
carried over from the tissue isolation so that the omission effect
was masked.
As was the case with cis-chlordane binding to protein, there was
a statistically significant (P

<

0 . 01) but not dramatic phenobarbital

mediated increase in binding to protein when trans-chlordane was the
substrate (Table 2, part A).

This illustrates a departure from the

halobenzene and halomethane compounds similar to that seen in the
cis-chlordane protein binding results.

It may be appropriate to
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conclude, then, that although trans-chlordane binding to protein is
more close ly analogous to the bromobenzene model system than cis-chlordane, there was not sufficient evidence generated in this study to
allow one to state that they behave the same.

Epoxide hydratase seemed

to be involved in trans-chlordane binding but not that portion of the
activity that is inducible.

Phenobarbital induction generally in-

creased binding to protein by the trans-isomer but the increase was uneffected by the inhibition of the mixed-function oxidases.
The Effect of .Chlordane Pretreatment on
Hepatic Epoxide Hydratase Activity
There have been no investigations reported in the literature in
which the effect of chlordane induction on microsomal hepatic epoxide
hydratase activity was studied.

The closest anyone seems to have

come is the work of Bellward, et al . (100) in which it was reported
that dieldrin contaminated feed increased activity in rats considerably.

Faced with this dearth of information and the well documented

metabolism of chlordane to one or, possibly, more epoxides I felt that
the effect of chlordane pretreatment on the activity of this inducible
enzyme had to be investigated before meaningful conclusions could be
reached about binding by chlordane derived material.
Table 3 shows the results of chlordane pretreatment on epoxide
hydratase activity in the mouse and the rat.

The difference in the

rate of metabolism of styrene oxide with induced and noninduced rat
liver is shown in figure 9.

The results are quite clear.

Both the

rat and the mouse show an increase in liver microsomal epoxide hydratase activity following 10 days of induction with 100 ppm of
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chlordane in feed.

Probably significant in this context is the fact

that the mouse shows a much greater degree of induction than the rat.
The results showed 2.3 to 3.2 times the amount of induction found in
the rat depending on the isomer used in the pretreatment.

Rat pre-

treatment, of course, was with the cis-trans (3:1) mixture already
mentioned so a comparison on an isomer basis was not possible.
Based on the variability of the results of the binding it is
difficult to say what effects these differences produced in the actual
metabolism of the chlordanes in the two species studied.

In virtually

all cas es induction caused a drop in binding in the rat (Table 1).
Since the pretreatment also induced mixed-function oxidase activity,
it i s impossible to conclude what increment of this reduction was due
to epoxide hydratase activation or whether increased epoxide hydratase activity had any effect on binding at all.

It is clear from the

r esult s s hown in table 1, part A that inhibition of epoxide hydratase
had the effect of increasing binding to protein in the rat in both
induced and noninduced groups.

So the enzyme must have been involved

in a metabolic deactivation toward protein binding in this species.
The s ame comparison in the mouse (Table 2, part A) is confounded by
pretreatment and substrate effects.

Inhibition also had a striking,

but opposite, effect on binding to DNA in the mouse system as was
already di scussed (vide supra).
It may be that the activating effect of the hydratase toward DNA
binding in the mouse plus the higher levels of epoxide hydratase
induction in the mouse contribute to the difference in relative carcinogenicity of chlordane in the rat and in the mouse.
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Suggested Areas for Further Investigation
The results of this study have suggested several areas for
further investigation.

Some are the result of what are felt to be

shortcomings in the present investigation while others are of a more
basic nature.

Most of the areas suggested for further study on this

problem and related areas will have to wait until the labelled pure
isomers again become available.
There were several shortcomings in these experiments that should
be examined in more detail pending the availability of the labelled
isomers .

The species differences in chlordane carcinogenicity found

in the National Academy of Sciences study might be explained if the
binding work with rat liver microsomes, reported here, could be repeated using the isomers instead of a cis-trans mixture.

It would be

particularly interesting to know if the inactivity of trans-chlordane
derived material toward DNA is universal or a phenomenon only associa ted with the C57 black/6J Fl hybred mouse.

Clarification of this may

show that the chlordane isomer s in concert with this mouse and the
rat, offer a system for the study of species variation in chemical
carcinogenesis.
Because of the doubts that have arisen in this work as a result
of the use of a passive method of mixed-function oxidase inhibition,
thi s work could be profitably repeated using a more specific method
for the inhibition.

Binding in the presence of mixed-function oxidase

inhibition and the failure to include a group in which both the mixedfunction oxidases and epoxide hydratase were inhibited, have caused
some doubt to arise as to just what enzyme or enzymes are participating in the activation of chlordane for binding.

The use of a more
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s pecific inhibitor of cytochrome P-450 along with trichloropropene
oxide would clear up this confusion to some extent.
Another area that might prove fruitful for additional research
is the participation of glutathione in the process that has been under
investigation here.

There is strong evidence from the work with bot h

the necrogens and the carcinogens that the presence of glutathione,
in a system like the one used in this work, has a very great modulating
effect on toxic events .

Rerunning these experiments using known gluta-

thione concentrations in the incubation mixtures and using microsomes
from animals dosed with a glutathione depleting substance would clarify the details of its involvement in the binding of chlordane metabolites to cellular macromolecules.

The only concession that was made

to the po ss ibility of glutathione participation in the present work
wa s the washing of the microsome s during their preparation.

The

incubat ion system was never actually as sayed for its presence.
Another area that need s attention is the metabolism of the chlordane isomers in the C5 7 bla ck/ 6J mouse .

Knowledge of the metabolic

pattern s for chlordane in th is animal would obviously have been
extremely helpful in the evaluation of the results generated in this
work.

It would be no less valuable applied retroactively.

Also, this

is work that could be carried out with unlabelled pure isomers which
eliminates the unavailability of the radioactive material as an impediment and an expense.
Finally, there are two aspects of chlordane metabolism that have
not been studied.

The first is the effect of in vitro metabolic

activation under anaerobic conditions.

Work with the halogenated

anesthetics (25) and the halomethanes (SO, 56) as well as work with
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chlordane has shown that reductive processes are involved in the
metabolism of these compounds.

In the case of the anesthetics and

the methanes, it has been shown that binding to protein is increased
by in vitro metabolism under anaerobic conditions.

A study of the

metabolism and binding of the chlordanes under these conditions could
have very interesting results.
The second aspect of chlordane that should be investigated is its
interaction with the blood forming tissues.

The suspicions of Furie

and Trubowitz (19) and Infante and Epstein (6) should be tested.

It

may be that although chlordane has not been found to be toxic to man
in the fashion that it is to rodents, the toxicity has eluded us because we have been looking in the liver and nervous system rather
than the bone marrow, which appears to be its site of action based
on the evidence from the epidemiologic studies.
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SUMMARY

This investigation addressed several aspects of the covalent
interaction of metabolites of the insecticide chlordane with cellular
macromolecules in vitro.

Microsomal preparations from the livers of

mice and rats were used and covalent binding to microsomal protein and
RNA and added calf thymus DNA was studied.

Pure 14 C-labelled cis- and

trans-chlordane isomers as well as an isomeric mixture (3:1, cis-to
trans-, 14 C) were used as · substrates for the in vitro system.

Bio-

chemical parameters investigated included inhibition of microsomal
mixed-function oxidase and epoxide hydratase plus the induction of
thes e enzyme s by pretreatment with chlordane or phenobarbital.

The

ef fect of the s e manipulation s on covalent interaction of the metabol i t es wi th the macromolecules was of interest.
I s olation of the protein, RNA and DNA from the in vitro microsomal systems after 30 min. incubations and scintillation counting
indicated that the chlordane derived material bound to all of the
macromolecules investigated.

The only exception was the trans-

i somer's interaction with DNA in the mouse liver system.

Mouse liver

microsomes do not activate tran·s-chlordane to a form which binds to
DNA in measurable amounts under the conditions employed here.
Results from this work indicated that microsomal epoxide hydratase and aminopyrine demethylase activity are increased in both the
rat and the mouse following chlordane pretreatment.

The effect of

thi s induction on the macromolecular interaction of metabolites was
variable for both chlordane and phenobarbital pretreated groups.
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Generally, for the mouse, induction increased binding to protein and
DNA and decreased binding to RNA.

In the rat induction decrea sed

binding to all of the macromolecular species.

The effect of enzyme

inhibition was variable in both species under all of the conditions
tested.

However, in the mouse epoxide hydratase inhibition reduced

binding by cis-chlordane to DNA to unmeasurable levels.
The results indicate little possibility that the epoxide metabolite of chlordane, oxychlordane, is involved in the binding .

The

effects of epoxide hydratase inhibition, however, indicate that some
epoxide is involved in cis-chlordane binding to DNA in the mouse.
The possible analogy between the binding behavior of chlordane
found in this study and the binding behavior of other well characterized toxic compounds is discussed.
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Appendix A
Tabular Results of the Statistical Analyses

Table 6.

Covalent interaction of 14 C-chlordane with cellular macromolecules during metabolism by
rat liver microsomes. Analysis of variance applied to the data summarized in table 1
using the method of unweighted means.a
Mean squares for the factor analysed

Source of variation
Pretreatment
Enzyme effectsc
Interaction
Within cells variation
(Error)
Pretreatment
Enzyme effects
Interaction
Within cells variation
(Error)

Degrees of freedom
1

3
3

32

Protein
**
0.3813
0.0125
0.0488*

0.0028
0 . 0010
0.0014

0.0110

0.0014

3

0.00096
0.00011
0.00011

24

0.00121

1
3

aBecause of unequal treatment group sizes due to pipetting error and a laboratory accident the usual
analysis of variance technique could not be applied here. Unweighted means analysis provides an alternative method for analyzing data such as these when the unequal group sizes arise randomly as they did here.
The DNA analysis is separated from protein and RNA because 2 additional DNA samples were lost leading to
fewer within cells (error) degrees of freedom.
cThe experimental design was conceived to allow separate analysis of the effects of the inhibition of mixedfunction oxidase and epoxide hydratase. Biochemical good sense and the hypothetical model indicated that
inhibition of both at the same time was unnecessary. Therefore, no treatment group was included in which
both enzymes were inhibited. This destroyed the symmetry of the factorial des ign and made it necessary to
combine these into one category .
*Indicates significance at the 95% level. **Indicates significance at the 99% level.

Table 7.

Values oft and indications of significance for various comparisons of group means in the
data from the rat.a
Comparisons

Number Pretreatment
A.

Values of tb

Microsomal enzyme activity
MFO
HEH

Target macromolecules
RNA

DNA

Tests of the significance of enzymatic manipulation.c
None

+

+

1.

None
Chlordane
2

Prote i n

+

+

0

Chlordane

0.8861

0 7511

1.8181 *

0.1266

0 0773

1.1422

1. 6465 *

0.1502

0.4494

0.6732

0.1024

0

0

+

None

+

None

+

+

3.

Chlordane

+

4.

Chlordane

0.4902
+

+

-------------- -------------------------------------------------------- -------------------------- ---------....
N

co

Table 7.

Continued

Values of tb

Comparisons
Number Pretreatment
B.

Microsomal enzyme activity
MFO
HEH

Protein

Target macromolecules
RNA

DNA

Test of the significance of chlordane pretreatment.d
None

+

Chlordane

+

+

2.9906**

5.

4.5763**

1.0526

aComparisons shown are for groups of varying sizes and were carried out using the results of the
analysis of variance by the unweighted means technique. Values of t .were calculated using the group means
arising from the unweighted means analysis. T-test variance used error mean square and N for each group
m15an.
Numbers of degrees of freedom in t-tests for protein and RNA were 32 and for DNA 24.
cEnzymatic manipulation refers to the inhibition of mixed-function oxidases (MFO) and hepatic epoxide
hddratase (HEH). A minus (-) indicates inhibited enzyme.
Pretreatment was carried out with the cis-rich chlordane mixture (25% pure trans-chlordane and 75% pure
cis-ch l ordane on a weight to weight basis) in feed for 10 days at a concentration of 100 ppm.
*Indicates significance at the 95% level. **Indicates significance at the 99% level.

....
N

"'

Table 8.

Covalent interaction of 14 C-chl ordane with ce llul ar macromolecu le s during metaboli sm by mou se
liver microsomes. Analysis of var iance applied to the data summar ized in t abl e 2.a

Source of variation

Degr ees of freedom

Treatment
Substrate
Pretreatment
Enzyme effects
Substrate x pretreatment
Substrate x enzyme effects
Pretreatment x enzyme effects
Interaction

17
1
2
2
2
2
4
4

Mean square s f or the factor analy zed
DNAC
Proteinb
RNA
0.0314**
0. 1183**
0.0406 **
0.0007
0.0208
0. 0272:
0.0364
0. 0229*

*
0.0496
0 . 6805**
0.0031
0 .0286*
0 . 0202
0.0068
0.0074
0. 0040

Error

35
0062
0. 0080
-------------------- -- ----------------------------- ----0.----- ---------------------------------------------

Treatment
Pretreatment
Enzyme effects
Pretreatment x enzyme effects
Error

5
2

0.00064

o.oouo*

2

0.00060
0. 00030

12

0.00028

1

a
.
.
bAnalys1s of var1ance was according to a completely randomized factorial design .
The values for the group variances in the pro tein groups deviated from normality so a log transformation
was applied prior to analysis of variance. RNA values required no transformation.
eDNA va lues were transformed to square roots to compensate for non normality of group variances. A substrate comparison within the DNA data was impossible. Trans-chlordane binding was unmeasurable or nonexistent leading to values of 0 for binding. Zero values violate the variance normality assumpt ion nece ssary for the use of the analysis of variance.technique.
*Indicates significance at the 95% level .
Indicates significance at the 99% level.

Table 9.

Values of t and indications of signifi c ance for various group mean comparisons in the data
from the mouse.a
Com arisons

Number Pretreatment Substrate
A.

Values of tC

Microsomal
MFO

enz~e

activitz:b

HEH

Protein

Target macromolecules
RNA

DNAO

Tests of the significance of mixed-function oxidase inhibition.
None

Cis

None

Cis

Cis

Cis

Cis

Cis

Phenobarbital

Cis

Phenobarbital

Cis

+

+

l.

+

4.5627**

0.4233

l. 2924

0. 9480

2.0867

l. 0107

3.3076*

0.7370

0.2000

0.9615

l. 6450

2.1014

0.5290

+

2.
+

+

+

3.

None

Trans

None

Trans

+

Trans

Trans

+

Trans

Trans

+

+

+

4.

5.

....
""....

Table 9.

Continued
Values of tc

Comparisons
Number Pretreatment Substrate

Microsomal enzyme activityb
MFO
HEH

Phenobarbital

Trans

+

Phenobarbital

Trans

+

Protein

0.7460

0. 2011

6.

B.

Target macromolecules
RNA

Tests of significance of epoxide hydratase inhibition.
None

Cis

None

Cis

Cis

Cis

+

Cis

Cis

+

Phenobarbital

Cis

+

Phenobarbital

Cis

+

None

Trans

+

None

Trans

+

+

7.

3.2276~

0.0995

1.3359

0.2575

1.3670

1.3111

+

8.

+

9.

+

3.3484

10.

*

1. 3819

3 .5697*

Table 9.

Continued
Values of tc

Comparisons
Microsomal enzyme activityb
Number Pretreatment Substrat e

~IFO

Trans

Trans

Trans

Trans

+

Phenobarbital

Trans

+

Phenobarbital

Trans

+

HEH

ll.

Target macromolecules
RNA

0.0902

1.4354

0. 6046

l. 6975

l. 6320

0.3781

1.3064

9. 0800 **

0.7767

0.9494

3.0295 *

0.1988

+

12.

c.

Protein

Tests of the significance of pretreatment.
None

Cis

+

+

Cis

Cis

+

+

None

Cis

+

Phenobarbital

Cis

+

None

Trans

+

Trans

Trans

+

13.

14.

15 .

+

Table 9.

Continued
Comparisons

Values of tc

~licrosomal enzyme activityb
Number Pretreatment Substrate

MFO

HEH

None

Trans

+

+

Phenobarbital

Trans

+

+

16.

D.

Protein

Target macromolecules
RNA

2.0579

0.8282

0.1651

3.2378*

l. 0857

3.0710

7.4855 **

2.9831 *

0.5173

4.0990

Tests of the significance of substrate.
None

Cis

+

+

None

Trans

+

+

Cis

Cis

+

+

Trans

Trans

+

Phenobarbital

Cis

+

+

Phenobarbital

Trans

+

+

None

Cis

+

None

Trans

+

17.

18.

19.

20.

..

Table 9.

Continued
Values of tc

Com arisons
Microsomal enzyme activityb
Number Pretreatment Substrate

MFO

Cis

Cis

+

Trans

Trans

+

Phenobarbital

Cis

+

Phenobarbital

Trans

+

HEH

21.

22.

None

Cis

None

Trans

Cis

Cis

+

Trans

Trans

+

Phenobarbital

Cis

+

Phenobarbital

Trans

+

23.

24.

Protein

1.7083

0.9993

3 . 0059*

4. 45oo**

4. 5807**

3 . 4105.

2 . 2447

2. 04 79

25 .

Target macromolecules
RNA

* ·

4.7191 **

2.8815*

Table 9.

Continued
Values of tc

Comparisons
Number Pretreatment Substrate

Microsomal enzyme activityb
MFO
HEH

Protein

Target macromolecules
RNA

~Values of t represent comparisons of the means of the 3 observations from each treatment group.
Microsomal enzyme activity refers to the state of mixed-function oxidase (MFO) and hepatic epoxide
htdratase (HEH). A minus (-) indicates inhibited enzyme.
dVa l ues of t with 4 degrees of freedom.
Binding to DNA by trans-chlordane derived material was unmeasurable .or nonexistent and yielded a value
of 0. For this reason, evaluations of statistical significance were impossible. Additionally, HEH ·
inhibi t ion led to values of 0 for binding of cis-chlordane derived material to DNA in comparisons 7 and
8. No t-test was possible on these values either.
*Indicat es significance at the 95% level. **Indicates significance .at the 99% level.
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Appendix B
Preliminary Experimental Work and Methods Development
The first indications that chlordane participated in binding to
cellular constituents arose during the investigations of Street and
Blau (103, 107).

They found that total recovery of pure chlordane

isomers from in vitro metabolism was incomplete and consistantly varied
with the isomer used as substrate.

Possible explanations for this

included covalent binding so an experiment was carried out in 1974 to
test this possibility.
Briefly, pure

14 C-labelled

cis- and trans-chlordane isomers were

incubated in vitro with microsomes prepared from the livers of rats
pretreated with DDT.

The individual incubates were extracted with

hexane after an appropriate incubation period to remove organic
soluble parent compound and metabolites.

The aqueous fraction was

then acidified to pH 2.0 precipitating the microsomal protein.

The

aqueous fraction plus precipitated protein was then exhaustively extracted (24 hours) with diethyl ether.

The proteinaceous residuum

was collected by millipore filtration, submitted to oxygen flask
combustion and bound radioactivity was determined by scintillation
counting of the evolved·

14 C0 •
2

The results of this work are shown in table 10.

The indications

were that binding was occurring at some site in the acid precipitable
proteinaceous remainder and that an isomeric prefer ence for material
derived from trans-chlordane was at work in the DDT induced rat liver
system.
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Table 10.

Substrage
1somer

The results of the preliminary investigation of covalent
binding by chlordane derived material in rat liver
microsomes.a

Inducerc

Inhibitord

Nanomoles of chlordanee
mg microsomal protein

cis
trans

DDT
DDT

None
None

0.172
0.099

cis
trans

DDT
DDT

TCPO
TCPO

0.197
0.486

aln vitro incubation performed with microsomes prepared from the
liver50rfemale Sprague- Dawley rats. 4. 7 mg microsomal protein per
incubate. Four repetitions of each treatment were made but incubates
were pooled before the protein was collected and combusted so no
igdex of variability has been included.
The substrate concentration was 1.2 X l0- 5 M.
cAnimals were induced with 150 mg/kg DDT in corn oil i.p. once a day
f8r three days.
An inhibitor of hepatic epoxide hydratase, 1,1,1-trichloropropene
oxide, was included at a concentration of 1.3 X lo-5 M.
eThese weights are based on the oxygen flask combustion of the
recovered dried proteinaceous residuum.
Following this preliminary experiment and prior to the start of
the experimental work, several questions had to be addressed.

These

revolved mainly around two points in the proposed dissertation work.
Firstly, there was a need to determine that the exogenous DNA
being added to the in vitro system was free from protein.

Additional-

ly, the purity of the nucleic acids and protein reisolated after in
vitro incubation had to be established.
contamination be kept to a minimum.

It was imperative that cross

Without these assurances, the

credibility of a report of binding to any one of the macromolecules
of interest would be questionable at best.
Secondly, certain changes had to be made in the in vitro chlordane metabolizing system used in previous work to accommodate added
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DNA and enzyme inhibitors and to allow for the isolation of the
macromolecular components.

The integrity of the chlordane metabolic

system had to be tested in the presence of these changes and the effect
of the components of the in vitro system on the added DNA had to be
established.
Pretreatment of calf thymus DNA prior
to use in binding studies
Sodium DNA from calf thymus (Type I) purchased from Sigma Chemical Co. was assayed at the source by the Lowry method and reported
to contain 2.3% protein.

A confirmatory protein determination by the

same method in our laboratory showed a protein content of 6.2%
(average of two samples).

It was felt that this was too much contamin-

ation for this work so the DNA was further deproteinized by the method
of Kay, et al. (118).
After deproteinization, a second protein determination was carried
out.

This showed that protein contamination had been reduced to 3.3%

(average of two samples).

The once purified DNA was again subjected

to the Kay procedure and the level of protein was determined as
before.

The twice deproteinized DNA was found to contain less than 1%

protein.
The DNA used in the bulk of the experimental work was sodium DNA
(Type II) from calf thymus purchased from Sigma Chemical Co. at a
later date.

Upon arrival, this material was subjected to the Kay

procedure immediately.

The only difference between the treatment of

this DNA and that purchased earlier was that the type II DNA was carried through an additional protein precipitation step.

Assay of this

material showed less than 0.9% protein (average of five samples).
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This was considered to be adequate purity.
Tests of the purity of DNA recovered from in vitro metabolism
by the method of Speier and Wattenberg (123)
The purity of the DNA recovered from the in vitro microsomal
metabolic system was also of concern.

Contamination at this point was

an indication of incomplete separation of 14 C-labelled DNA from microsomal RNA and protein containing bound 14 C-chlordane residues.

To

test the purity of recovered DNA nine incubation mixtures, complete
with the exception of 14 C-labelled chlordane, were incubated at 37°
for 30 minutes.

The DNA was separated from the microsomes by ultra-

centrifugation and decantation as outlined in the methods section.
Protein determinations run on appropriate aliquots of this recovered
DNA showed an average of 1% contamination.
Two subsequent changes in the procedure for the treatment of DNA
recovered from the microsomal incubation mixtures substantially reduced this contamination.

As is indicated in the methods section, the

Sevag procedure (124) was inserted at one point.

Additionally, the

use of DNAase to so lubil ize recovered DNA was dropped in favor of hot
perchloric acid hydrolysis (119) followed by collection of acid
insoluble material by centrifugation.

This eliminated the necessity

for adding further protein contamination in the form of DNAase to the
already highly purified DNA preparation.
Optimization of the conditions for the
epoxide hydrase assay
Early trouble with the determination of hepatic microsomal
epoxide hydrase activity indicated the necessity for establishing
optima for microsome concentrations, incubation time and inhibitor
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concentration in the assay mixture.

To establish proper incubation

time and microsomal protein concentration, an experiment was run in
which these two factors were varied.
11.

The results are shown in table

As a result of this experiment, the incubation time used in the

experimental assays was extended from the 5 minutes called for in the
procedure (92) to 15 minutes and the protein level used in the experimental assays was approx. 0.48 mg/sample.

This concentration was at

the high end of the range called for in the Oesch procedure (92) and
corresponded to the addition of 0.2 ml of the 1:4 (w:v) microsomal
suspension used in the chlordane incubations.
Optimization of the concentration of TCPO for
inhibition of epoxide hydrase activity
A diversity of claims in the literature for the effectiveness of
TCPO in inhibiting epoxide hydrase activity (26, 126) led to some confu s ion about the quantity that should be added to give metabolically
significant and measurable inhibition of the enzyme.

A trial was set

up in which a series of concentrations were used that covered the
range of those reported in the literature.

The results of this trial

are presented in table 12 .
The decision was made to use the middle value.
three factors:

This was based on

1) The fact that this concentration (5 X 10- 4 M) was

reported by Oesch (26) as an acceptable level for inhibition .
2)

There was no significant increase in inhibition to be gained in

going to the next higher concentration (5 X lo-3 M).

3) Concentra-

tions of the inhibitor had to be kept as low as possible to avoid unwanted biochemical effects such as competition with substrate for cyt.
P-450 in the complete in vitro chlordane metabolizing system.
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Table 11.

Optimization of microsomal protein concentration and incubation time in the assay of hepatic epoxide hydratase
activity (See page 74 for details of the assay procedure).a

Microsomal
protein concentration (mg)

Incubation
time (min.)

0.48
0.48
0.48
0.48

5
10
30
60

0.26
0.35
0.81
0.90

2.38
2.38
2.38
2.38

5
10
30
60

lost
0.22
0.30
0.18

4.76
4.76
4.76
4.76

5
10
30
60

0.06
0.07
0.09
0.12

aOne sample per incubation time.
tion 2.0 mM.
Table 12.

X 10- 5

10- 4

X 10- 3

5

Micrograms

1 4 c-styrene

glycolb

% inhibition

35. 2

±

1. 2

0

M

22.3

±

3.5

37

M

19.5

±

17.8

45

M

19.1

±

17.8

46

None

X

Substrate styrene oxide concentra-

Studies on the optimal concentration for the inhibition of
hepatic epoxide hydratase with 1,2-epoxy-3,3,3-trichloropropane (TCPO).a

TCPO Concentration

5

Micromo1es styrene glycol
per mg microsomal protein

aAssay conditions: 0.2 ml of an uninduced microsomal preparation
from rat liver containing an average of 0.231 mg of protein, 2.0 mM
with respect to substrate styrene oxide concentration, 15 minute incubgtions at 37°.
Each value represents the average of 3 samples ± standard deviation .
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Tests of the effect of the pre sence of oxychlordane
on the activity of epoxide hydrase
To assess the effect of oxychlordane generated during chlordane
metabolism in vitro, an experiment was conducted that was similar to
the one just described.

Three oxychlordane solutions were made up in

acetonitrile such that the addition of a suitable aliquot would render
the epoxide hydrase assay mixture either 5 X lo- 5 , 5 X 10- 4 or 5 X
10- 3 molar with respect to oxychlordane.

The substrate concentration

in the assay mixture is 2 X 10- 3 molar .

The results are presented in

table 13.

They indicate that there was no inhibition of epoxide

hydrase at any of the oxychlordane concentrations tested.

The effect,

in fact, appears to be a slight enhancement of epoxide hydra se
activity.
Table 13.

The effect of various concentrations of oxychlordane on
hepatic epoxide hydrase activity in rat liver microsomes.a

Oxychlordane
concentrationb
None
5 X 10-

5

Micrograms

14 C-styrene

glycolc

% inhibition

35.2

i

1.2

0

M

36.9

i

14.0

less than 0

5 X 10- 4 M

43.0

i

2.1

less than 0

X 10- 3 M

39.4

i

2.4

less than 0

3
Assay conditions: 0 . 2 ml of an uninduced microsomal preparation
from rat liver containing an average of 0.231 mg of protein, 2.0 mM
with respect to substrate styrene oxide concentration, 15 minute
igcubations at 37°.
Oxychlordane used was an analytical reference standard supplied by
the Velsicol Chemical Co. 98% purity .
cValues are an average of 3 samples ± standard deviation.
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